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Abstract 
Cancer is one of the leading causes of death in modern world. Though plenty of 
drugs have been developed for chemotherapy, most of them pose severe side effects 
on the patients which make the patients even more vulnerable. Undoubtedly, there is a 
need to search for more effective and safe anti-cancer drugs. Traditional herbal 
medicine has gained attention for its long history and mild action on the body, 
therefore providing us with a rich source of relatively safe phytochemicals for 
anti-cancer drug screening. 
The anti-tumor activities of Acanthopanax were reported previously, for instance, 
it can inhibit the proliferation of leukemia cell line HL-60 and stomach cancer cell 
line KATO III. However, the mechanism behind this anti-tumor effect remains unclear. 
Therefore, the anti-tumor effect of Acanthopanax and its mechanism of action were 
studied in this project. 
Acanthopanax was initially extracted through the process of boiling under reflux 
with water for 2 hours. Its in vitro and-proliferative activities on different human 
cancer cell lines (MCF-7, MDA-MB-231 and Hep G2) were examined by the 
colorimetric MTT assay. The aqueous extract of Acanthopanax could inhibit the 
growth of tested cancer cell lines in a dose-dependent manner and the ICso was around 
400 [ig/m\. To further investigate the anti-turnor activities, the methanol extract of 
i i i 
Acanthopanax was partitioned and column chromatography was performed on the 
ethyl-acetate fraction. It was found that one of the sub-fractions (Fc) generated from 
column chromatography was able to induce apoptosis in the breast cancer cells, with 
an IC50 of about 42 ^ig/ml and 65 |jg/ml towards MCF-7 and MDA-MD-231 cells 
respectively. Apoptotic features such as mitochondrial membrane depolarization, 
phosphatidyl-serine externalization and DNA fragmentation could be observed in the 
MDA-MB-231 cells after 48 hour treatment with Fc. By Western blotting, it was 
revealed that Fc could induce the intrinsic apoptotic pathway by reducing expression 
of Bcl-2, procaspase-9 and procaspase-3 and PARP in MDA-MB-231 cells. On the 
























List of Abbreviations 
AIF Apoptosis inducing factor 
Apaf-1 Apoptotic protease activating factor 1 
APC Antigen presenting cell 
APS Ammonium persulphate 
AV Annexin-V 
BCA Bicinchoninic acid 
BSA Bovine serum albumin 
CAD Caspase activated deoxyribonuclease 
CARD Caspase recruitment domain 
Cdk Cyclin dependent kinase 
ConA Concanavalin A 
COX Cyclooxygenase 
DcRl Decoy death receptor 1 
DD Death domain 
DED Death receptor domain 
DIABLO Direct lAP binding protein with low pi 
DISC Death inducing signaling complex 
DM Diabetes Mellitus 
DMSO Dimethylsulfoxide 
EAT Ehrlich Ascites Tumor 
endoG Endonuclease G 
ER Estrogen receptor 
FADD Fas-associating protein with death domain 
FBS Fetal bovine serum 
FLIP FLICE inhibitory protein 
HCC Hepatocellular carcinoma 
ICAD Inhibitor of caspase activated deoxyribonuclease 







MTT 3-(4,5-dimethylthiazolyl)-2,5-diphenyl-tetrazolium bromide 
NK cells Natural killer cells 
vii 
NO Nitric oxide 
PARP Poly (ADP-ribose) polymerase 
PBMC Peripheral blood mononuclear cell 
PBS Phosphate-buffered saline 
PGE2 Prostaglandin E2 
PHA Phytohemagglutinin 
PMS Phenazine methosulfate 
PI Propidium iodide 
PS Penicillin-Streptomycin 
PS Phosphatidylserine 
PVDF Polyvinylidene fluoride 
RIP Receptor-interacting protein 
Smac Second mitochondria-derived activator of caspases 
TEMED Tetramethylethylenediamine 
TNF Tumor necrosis factor 
TNFR Tumor necrosis factor receptor 
TLC Thin layer chromatography 
TRAIL TNFR apoptosis-inducing ligand 
XIAP X-chromosome linked inhibitor of apoptosis 
XTT Sodium 3 ' - [ l - (phenylaminocarbonyl)- 3,4- tetrazolium]-bis 
(4-methoxy- 6-nitro) benzene sulfonic acid hydrate 
viii 
List of Tables 
Table 2.1 Reagents and buffers used in DNA fragmentation 32 
Table 2.2 Reagents and buffers used in Western blotting 33 
Table 3.1 Extraction yield of Astragalus, Maitake and Acanthopanax 51 
Table 3.2 Partition yield of Acanthopanax 57 
Table 3.3 Yield of sub-fractions of column chromatography 60 
Table 3.4 Summary of IC50 of various sub-fractions 66 
Table 3.5 Summary of cell cycle analysis 87 
ix 
List of Figures 
Fig. 1.1 Schematic representation of intrinsic pathway of apoptosis 23 
Fig. 1.2 Schematic representation of extrinsic pathway of apoptosis 26 
Fig. 3.1 Effect of Astragalus extracts on proliferation of cancer cells 53 
Fig. 3.2 Effect of Maitake extracts on proliferation of cancer cells 54 
Fig. 3.3 Effect of Acanthopanax aqueous extracts on proliferation of cancer 
cells 55 
Fig. 3.4 The chromatograms of various partition extracts of Acanthopanax...58 
Fig. 3.5 Effect of parti t ion extract hexane and chloroform on MCF-7 and 
MDA-MB-231 cells 61 
Fig. 3.6 Effect of partition extract ethyl-acetate and butanol on MCF-7 and 
MDA-MB-231 cells 62 
Fig. 3.7 The chromatograms of sub-fractions Fb - Fh of Acanthopanax 63 
Fig. 3.8. Effect of sub-fraction Fa on the proliferation of MCF-7 and MDA-MB-231 
c e l l s 6 7 
Fig. 3.9. Effect of sub-fraction Fb on the proliferation of MCF-7 and MDA-MB-231 
c e l l s 6 8 
Fig. 3.10 Effect of sub-fraction Fc on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 cel ls 69 
Fig. 3.11 Effect of sub-fraction Fd on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 cells 70 
Fig. 3.12 Effect of sub-fraction Fe on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 cells 71 
Fig. 3.13 Effect of sub-fraction Ff on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 cells 72 
Fig. 3.14 Effect of sub-fraction Fg on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 ce l l s 73 
Fig .3.15 Effect of sub-fraction Fh on the proliferation of MCF-7, MDA-MB-231 and 
HS 68 cells 74 
Fig. 3.16. Effect of sub-fraction Fi on the proliferation of MCF-7 and MDA-MB-231 
c e l l s 7 5 
Fig. 3.17 Effect of sub-fractions on the proliferation of PBMC 77 
Fig. 3.18. Effect of sub-fraction Fc on the proliferation of MCF-7 and MDA-MB-231 
c e l l s a f t e r 24 and 48 h o u r s of t r e a t m e n t 78 
Fig. 3.19 Effect sub-fraction of Fc on MDA-MB-231 cells mitochondrial membrane 
p o t e n t i a l 8 1 
Fig. 3.20 Effect of sub-fraction Fc on MCF-7 cells mitochondrial membrane 
potential 82 
V 
Fig. 3.21 Effect of sub-fraction Fc on the induction of apoptosis in MDA-MB-231 
cells 83 
Fig. 3.22 Effect of sub-fraction Fc on the induction of apoptosis in MCF-7 
cells 84 
Fig. 3.23 Effect of sub-fraction Fc on MDA-MB-231 cell cycle progression 85 
Fig. 3.24 Effect of sub-fraction Fc on MCF-7 cell cycle progression 86 
Fig. 3.25 DNA fragmentation analysis of MDA-MB-231 cells 89 
Fig. 3.26 DNA fragmentation analysis of MCF-7 cells 90 
Fig. 3.27 Effect of sub-fraction Fc on the expression of Bcl-2 of MDA-MB-231 
cells 93 
Fig. 3.28 Effect of sub-fraction Fc on the expression of procaspase-9 andcaspase-
9 of MDA-MB-231 cells 94 
Fig. 3.29 Effec t of sub-fract ion Fc on the expression of procaspase-3 of 
MDA-MB-231 cells 95 
Fig. 3.30 Effect of sub-fraction Fc on the expression of PARP of MDA-MB-231 
cells 96 
Fig. 3.31 Effect of sub-fraction Fc on the expression of cyclin D| of MCF-7 
cells 97 
Fig. 3.32 Effect of sub-fraction Fc on the expression of cdk 2 of MCF-7 cells...98 
xi 
Contents 
Thesis / Assessment Committee i 
Acknowledgement ii 
Abst rac t (Engl ish) iii 
Abstract (Chinese) v 
List of Abbreviations vii 
List of Tables ix 
List of Figures x 
Chapter 1 Introduction 
1.1. Overview of cancer 1 
1.1.1 Breast cancer 1 
1.1.2 Hepatocellular carcinoma (HCC) 2 
1.2. Role of natural products in the fight against cancer 3 
1.2.1 Introduction of Astragalus memhranaceus 4 
1.2.2 Introduction of Acanthopanax senticosus 9 
1.2.3 Introduction of Grifola Frondosa 13 
1.3. Apoptosis and cancer 17 
1.3.1 Caspases 20 
1.3.2 Intrinsic apoptotic pathway 21 
1.3.3 Extrinsic apoptotic pathway 23 
1.3.4 Execution of apoptosis 26 
1.4 Cell cycle and cancer 27 
1.5 Objective of this project: 29 
Chapter 2 Materials and Methods 
2.1 Materials: 30 
2.1.1 Culture medium 30 
2.1.2 Buffers and reagents 31 
2.1.3 Herbs 34 
2.2 Methods 35 
2.2.1Cell cultures 35 
2.2.1.1 Cell lines 35 
2.2.1.2 Cell culture techniques 36 
2.2.1.3 Cryopreservation of cell lines 36 
2.2.2 Proliferation assay 37 
2.2.2.1 MTT assay 37 
2.2.2.2 Isolation of PBMC 38 
2.2.2.3 XTT 39 
2.2.3 DNA fragmentation 39 
xi i 
2.2.4 Flow cytometry 41 
2.2.4.1 Detection of mitochondrial membrane depolarization by the use 
of JC-1 41 
2.2.4.2 Annexin-V-FITC PI labeling of apoptotic cells 42 
2.2.4.3 Cell cycle analysis 43 
2.2.5 Western blotting 43 
2.2.5.1 Total protein extraction 44 
2.2.5.2 Determining protein concentration 44 
2.2.5.3 SDS-PAGE 45 
2.2.5.4 Electroblotting 45 
2.2.5.5 Probing 46 
2.2.5.6 ECL 46 
2.2.6 Preparation of herbal extracts 47 
2.2.6.1 Preparation of extract of Astragalus memhranaceus and Grifola 
frondosa 4 7 
2.2.6.2 Preparation of Acanthopanax senticosus aqueous extract47 
2.2.6.3 Partition of Acanthopanax 47 
2.2.6.4 Column purification of ethyl-acetate fraction 48 
2.2.6.5 Analytical thin layer chromatography 49 
2.2.7 Statistical Analysis 50 
Chapter 3 Results 
3.1 Extractions 51 
3.2 Anti-proliferative effect of herbal extracts on cancer cell lines...51 
3.3 Partition of Acanthopanax methanol extract 56 
3.4 Anti-proliferative effect of Acanthopanax partition fractions on breast 
cance r ce l l s 59 
3.5 Column chromatography of ethyl acetate fraction 59 
3.6 Anti-proliferative effect of various sub-fractions on breast cancer 
cells 64 
3.7 Effect of sub-fractions on PBMC proliferation 76 
3.8 Kinetic study of anti-proliferative effect of Fc 76 
3.9 Flow cytometric analysis 79 
3.91 JC-1 staining 79 
3.92 Annexin-PI labeling 79 
3.93 Cell cycle analysis 80 
3.10 DNA fragmentation assay 88 
3.11 Western blotting 91 
Chanter 4 Discussion 99 
xi i i 
Chapter 5 Conclusion 124 
References 126 
xiv 
Chapter 1 Introduction 
1.1. Overview of cancer 
Cancer is one the leading causes of death in the world. Despite the medical 
advances, the mortality of cancer remains at a high level. Cancer accounts for 13 % of 
all deaths and caused the death of 7.6 million people in 2005. Cancers of lung, 
stomach, liver, colon and breast were listed as the top five cancers in causing mortality. 
Though the number of deaths caused is frightening enough, there are 10.9 million of 
new cancer cases and 24.6 million people are still living with cancer according to 
figures in 2002. More importantly is that the number of deaths from cancer is 
projected to grow in the future. From 2007 to 2030, an estimated growth as high as 45 
% is predicted in the number of global cancer deaths, meanwhile new cases of cancer 
are estimated to increase from 11.3 million in 2007 to 15.5 million in 2030 
(http://www.who.int/cancer). Since about 40 % of cancer deaths could be prevented, 
cancer prevention has become one of the major concerns of cancer development. 
However, to deal with such a large number of cancer patients, the urge to search for 
effective drugs in treating cancer is highly desirable. 
1.1.1 Breast cancer 
Breast cancer is a leading cause of mortality in women, especially in developed 
countries. In the United States, an estimated number of 46,000 women will die from 
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breast cancer every year with over 2,000,000 new cases adding to the number of 
breast cancer patients (Perera and Gui, 2003). The treatment of women in 
estrogen-dependent breast cancer has been improved, owing to the recent advances in 
diagnosis and therapy. Endocrine therapy has shown to be effective in treating 
estrogen-dependent breast cancer through deprivation of estrogen stimulation to 
breast tumor cells by either reducing the local and systemic estrogen concentration or 
blocking the estrogen receptor (Howell and Wardley. 2005). In contrast, the treatment 
for estrogen-independent tumors is not satisfactory and responses of breast cancer to 
anti-tumor agents are not very good (Bergh et al., 2001). Combination chemotherapies 
gave a better survival rate compared with monotherapies, and has become a standard 
treatment to metastatic hormone-refractory breast cancer. However, severe side 
effects and the development of resistance have hindered the effectiveness of such 
practices (Rock and DeMichele, 2003:Hsieh et al., 2005). 
1.1.2 Hepatocellular carcinoma (HCC) 
HCC is listed at the third place in causing mortality among different kinds of 
cancers. HCC is notorious for its high lethality, with a yearly fatality ratio near to 1. 
implying that most patients cannot survive for more than a year (Yoshida et al., 2005). 
Viral infections with hepatitis B or hepatitis C is the leading cause of hepatocellular 
carcinoma, therefore, the control of viral infection is an important measure in 
2 
preventing HCC prevalence (Omata and Yoshida, 2004). 
Surgical resection could possibly remove the entire HCC nodules. However, the 
option of surgery is only available to less than 20 % of HCC patients (Johnson, 2002). 
Even if surgical resection is possible, de novo carcinogenesis may still take place, 
probably due to the fact that the remaining liver is often cirrhotic. Therefore, the 
recurrence rate does not fall with time (Sakon et al” 2000). 
Treatment of HCC highly depends on chemotherapy. Unfortunately, the efficacy 
of chemotherapy is limited by the multi-drug resistance which is common in liver 
cancer, and over-expression of P-glycoprotein could be found in 50 - 70 % of the 
patients (Grude et al., 2002). Since liver is the organ responsible for detoxification in 
our body, liver malignancy would impair such function and as a result of this, the side 
effects of chemotherapy becomes even more prominent in HCC patients (Nowak et al., 
2004). 
1.2. Role of natural products in the fight against cancer 
Plant is a great source of natural products and provides lots of metabolites and 
most of them do not have any specific function in the plant and therefore termed as 
secondary metabolites. Throughout history, plant-based formulations have been used 
as medicine in treating various human and animal ailments (Singh et al., 2003) that 
have supplied a rich source of compounds that were applied in the field of medicine, 
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pharmacology as well as biology, and still playing a vital role in modern drug 
development. As many as 70 % of therapeutic drugs used nowadays were developed 
from plants (Sreenivasan et al.，2006). Many new natural compounds isolated from 
plants have been used as prototypes for later structural modification and give rise to 
compounds with practically useful pharmacological activities (Mukherjee et al., 
2001;Lee, 1999;Gordaliza, 2007). Successful examples include Camptothecin and 
Taxol. Camptothecin was first isolated from Camptotheca acuminata, and was 
discovered to exert its anti-tumor effect by inhibiting the topoisomerase I. Two 
analogues of camptothecin are now applied in the treatment of ovarian, colorectal, and 
small cell lung cancers, and there are newer analogues still under testing in clinical 
trials. Taxol isolated from Taxus brevifolia was found to inhibit cancer cell 
proliferation by stabilizing the microtubules. Taxol is currently used in the treatment 
of breast and non-small cell lung cancers and Kaposi's sarcoma (Oberlies and Kroll, 
2004). With a long history of more than a thousand years, the experience from 
traditional Chinese medicine can surely afford valuable information in the search for 
new antineoplastic drugs (Han, 1988). In the present study, we are interested in three 
herbs (Astragalus, Acanthopanax and Maitake) in particular. 
1.2.1 Introduction of Astragalus membranaceus 
As a tonic herb, the immunoregulatory effect of Astragalus is well-noted and 
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there are lots of reports regarding the action of Astragalus extract on the immune 
system. Astragalus extract could enhance the proliferation of murine splenocytes and 
human cord blood lymphocytes, and the effect is even more profound when it is 
co-treated with mitogens such as Lipopolysaccharide (LPS), Concanavalin A (ConA) 
or Phytohemagglutinin (PHA). The IL-2 receptor expression level of mouse 
splenocytes was also elevated after the in vitro treatment of Astragalus extract (Cho 
and Leung, 2007a). In addition, Astragalus administration also modulated other 
aspects of immunity as well, for instance, increasing superoxide anion production and 
promoting phagocytic activity of macrophages of mice, stimulating the NK cell 
activity of human peripheral blood lymphocytes and restoring the NK cell activity 
inhibited by steroid intake (2003). Astragalus could also stimulate the activity of 
cytotoxic T-lymphocytes and promote the TNF and IL-6 release from macrophages 
(Yoshida et al., 1997). 
It was proposed that the polysaccharide in Astragalus was responsible for the 
immunostimulatory effect. Astragalus polysaccharide exhibited mitogenic effect on 
splenocytes and splenic B cells, and stimulated the cytokine secretion including IL-ip 
and TNF-a from macrophages. It was shown that the Astragalus polysaccharide 
would bind to the surface of macrophages and B cells and the membrane 
immunoglobulin may act as the binding receptor in B cell activation (Shao et al., 
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2004). Another study showed that Astragalus polysaccharide could stimulate the 
production of NO in both iu vitro and in vivo conditions. The inducible NO synthase 
transcription was also increased through the activation of the N F - K B / R C I (Lee and 
Jeon, 2005). 
A vast number of studies about the effect of Astragalus on tumor cells were 
carried out and the results usually coincide to the same conclusion. Astragalus could 
modify the immune system in our body and help defending against cancer. In contrast, 
there were much fewer reports about the direct cytotoxicity of Astragalus towards 
cancer cells. A study tested the cytotoxicity of Astragalus extracts on a number of 
cancer cell lines including macrophage-like tumor J774 A.l, PU5-1.8, P388Di, 
myeloid tumors HL-60, Ml and WEHI-3, T-cell lymphoma MBL-2 and YAC-1, 
mineral oil-induced plasmacytoma NS-1，fibroblast-like tumor L929 and WEHI-164 
and Ehrlich ascites tumor EAT (Cho and Leung, 2007b). However, none of them 
shown significant decrease in cell viability after treating with Astragalus extracts 
although cytostatic effect could be observed, especially for macrophage-like tumor 
and myeloid tumor cells. On the other hand, Astragalus extract demonstrated 
anti-tumor activities when it comes to an in vivo environment, A significant reduction 
in number of viable tumor cells recovered from the peritoneal cavity of the mice after 
Astragalus administration was noted. Astragalus administration also inhibited the 
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growth of EAT in tumor-bearing mice (Cho and Leung, 2007b). Immunopotentiating 
effect could also be found in the same set of experiments. Administration of 
Astragalus extracts could result in the influx of macrophages into the peritoneal cavity 
and activating the phagocytic activity of peritoneal exudate cells in vivo while the in 
vitro treatment of macrophages with Astragalus extract led to increased cytostatic 
activity towards MBL-2 tumor. Injection of Astragalus extract together with LPS led 
to a much profound increase in the level of TNF-a in tumor-bearing mice when 
compared with that of LPS-injection alone (Cho and Leung, 2007b). Therefore，it is 
very likely that the anti-tumor effect in vivo of Astragalus was mediated through its 
immunoregulatory effect. 
Nevertheless, a recent report proposed that the total saponins from Astragalus 
could induce apoptosis and G2/M phase cell cycle arrest in human colon cancer cells 
HT-29 and demonstrated significant in vivo inhibition of tumor growth in nude mice 
xenograft, without lethal effect and did not cause significant drop in the body weight 
of the mice (Tin et al., 2007). In addition, it was reported that Astragalus extract could 
induce apoptosis in erythroleukemia HEL cells through stimulating apoptosome 
formation and activating caspase-3 (Cheng et al., 2004). Therefore, the anti-tumor 
effect of Astragalus may be partly contributed by its ability to induce apoptosis of 
malignant cells and it seems that whether Astragalus extract would induce apoptosis 
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in tumor cells depends on the cell line tested and the extraction method employed. 
Some reports have suggested the possibility of using Astragalus as an adjunct 
therapy, for example, a ten-fold potentiation of cytotoxicity of recombinant IL-2 
generated lymphokine-activated killer cells against murine renal carcinoma could be 
induced by Astragalus extract (Wang et al” 1992). Intravenous injection of Astragalus 
to tumor-bearing mice could restore the blastogenic response of splenic lymphocytes. 
On the other hand, intraperitoneal (i.p.) injection of Astragalus in mice could also 
reduce the immunosuppressive effect caused by cyclophosphamide administration 
(Cho and Leung, 2007a). A clinical study involving 120 tumor patients in China 
demonstrated that the immuno-stimulating effect of Astragalus is still valid in patients 
undergoing chemotherapy. The IgG and IgM levels were increased in 
Astragalus-treated patients. More importantly, the side effects caused by 
chemotherapy such as diarrhea, vomiting and proteinuria were lowered after 
Astragalus treatment when compared with that of the cancer patients with 
chemotherapy only (Duan and Wang, 2002). This result shows that Astragalus may 
help protecting our body during chemotherapy. In another randomized controlled 
clinical trial, Astragalus i.p. injection in combination with platinum-based 
chemotherapy has been shown to significantly reduce the risk of death at 12 months, 
compared with platinum-based chemotherapy alone (Zou and Liu, 2003). This result 
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shows that Astragalus may increase the effectiveness of treatment when used in 
combination with chemotherapy (McCulloch et al., 2006). 
In addition to the activities mentioned before, other biological activities of 
Astragalus were also reported. For instance, it was found that the saponins in 
Astragalus could inhibit the formation of lipid peroxides in the myocardium and 
decrease blood coagulation at the same time (2003). It was shown that Astragalus had 
an antioxidant effect in 43 patients suffering from acute myocardial infarction. The 
red blood cell superoxide dismutase activity was elevated and the lipid peroxidation 
content in the plasma was reduced as a result of Astragalus oral consumption (Chen et 
al., 1995). 
1.2.2 Introduction of Acanthopanax senticosus 
The reports about biological activities of Acanthopanax are versatile. It is 
regarded as an adaptogen which helps the body to cope with the effects caused by 
stress, anxiety, trauma and fatigue, and helps our body to maintain its best 
homeostatic state. It has been used to treat many kinds of stress-induced physiological 
changes as it was shown that Acanthopanax could modulate our body response to 
stress (Boon-Niermeijer et al., 2000), for instance it demonstrated protective effect of 
gastric ulcer on cold water-stressed mice (Fujikawa et al., 1996). This effect may be 
related to the ability of Acanthopanax to regulate the level of biogenic monoamines 
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including noradrenaline and dopamine in the brain (Fujikawa et al., 2002). Moreover, 
there are investigations showing that Acanthopanax could be used potentially in 
treating Diabetes Mellitus (DM), due to its antioxidant and anti-glycation activities 
(Lee et al., 2004a;Xi et al., 2008) or improving insulin resistance (Liu et al., 2005). 
The anti-hyperglycemic effect of Acanthopanax also attributed to the potential use in 
DM-related area (Park et al., 2006). Acanthopanax extract also exhibited anti-fatigue 
effect (Deyama et al., 2001), such as prolonging the time to exhaustion in chronic 
stressed mice (Nishibe et al., 1990) or increasing the exhaustion time of treadmill 
running and reduced the exercise-induced 5-hydroxytryptamine (serotonin) synthesis 
and tryptophan hydroxylase expression in the dorsal raphe (Rhim et al., 2007). Other 
activities such as neuroprotective effects (Fujikawa et al., 2005b;Fujikawa et al.， 
2005a;Jang et al., 2003;Bu et al., 2005) and effect on myocardial 
ischemia-reperfusion (Sui et al., 1994) were also noted. 
Acanthopanax also possesses regulatory effect on the immune system. There are 
some reports about its anti-inflammatory activities, such as inhibiting nitric oxide 
synthase activity in RAW 264.7 macrophages (Lin et al., 2008b) and reducing the NO 
production in murine macrophages (Lin et al., 2007). The administration of 
Acanthopanax extract could also reduce the LPS-induced production of PGE2, TNF-a 
and lower the COX-2 enzyme expression (Jung et al., 2003). Superoxide anion 
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production and hydrogen peroxide production from mouse peritoneal macrophages 
were suppressed by Acanthopanax extract treatment (Lin et al., 2008a) and the 
activities of antioxidant enzymes including superoxide dismutase, catalase and 
glutathione peroxidase were also elevated after oral intake of Acanthopanax extract 
(Lee et al., 2004b). It was also reported that the polysaccharides from Acanthopanax 
could stimulate the proliferation and differentiation of B cells and the cytokines 
release from macrophages and it was proposed that the Acanthopanax polysaccharide 
may act through binding to the toll-like receptors on B cells and macrophages (Han et 
al., 2003). 
There are some reports about the anti-tumor activities of Acanthopanax but the 
mechanisms of action described vary from one to another. A study in Japan 
investigated the effect of hot water extract of stem bark of Acanthopanax against 
stomach cancer. Their results showed that the Acanthopanax extract could inhibit the 
growth of KATO III cell line and induce apoptosis of it. The study also mentioned that 
one of its components, sesamin was responsible for the apoptosis inducing activity 
(Hibasami et al., 2000a). On the other hand, the anti-tumor effect of Acanthopanax 
was studied more extensively in mainland China. The polysaccharides from 
Acanthopanax were shown to be able to inhibit the growth of leukemia cell line K562 
and murine sarcoma cells SI80 in in vitro environment (Tong et al., 1994). It was 
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reported that Acanthopanax water extract was effective in inhibiting the growth of 
leukemia cells in vitro. Gel filtration column chromatography was applied to isolate 
the active constituents from the water extract. It was found that the anti-proliferative 
activity was associated with a protein component F2 and its size was about 64 kDa 
which demonstrated anti-proliferative effect on leukemia cell lines such as Raji and 
HL-60. After oral administration of F2 for ten days, the tumor size in tumor-bearing 
mice was significantly reduced compared to control group and the survival period of 
the tumor bearing mice was also prolonged after oral intake of F2 (Shan et al., 2004). 
Another in vivo study revealed that daily peritoneal injection of Acanthopanax extract 
could inhibit the growth lung cancer cells Lewis. Co-treatment of cyclophosphamide 
with Acanthopanax injection also demonstrated stronger anti-proliferative effects 
towards Lewis cells growth when compared with single cyclophosphamide treatment 
(Zhang et al., 2004). These studies showed that Acanthopanax extract was not only 
effective in inhibiting in vitro cancer cell growth, the tumor development in animal 
models was also repressed by Acanthopanax extracts. 
In addition, there are also reports about the anti-metastatic activity of 
Acanthopanax extract. Intra venous injection of Acanthopanax water extract GFIOO 
for 2 days before tumor cells inoculation was shown to be effective in lowering lung 
metastasis of colon tumor cell line colon 26-M3.1. Cytokine secretions such as IL-lp, 
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IL-12, TNF-a and IFN-y were elevated and both macrophages and natural killer cells 
were activated upon the GFIOO injection. The anti-metastatic activity could be 
abolished by removing NK cells in the in vivo model suggested that this 
anti-metastatic activity may be contributed by the modulating the immunity of the 
mice (Yoon et al., 2004). 
A clinical study involving 73 lung cancer patients was carried out in China. The 
results suggested that daily Acanthopanax extract injection could raise the level of, 
IgA, IgG, IgM and NK cell activities while decreasing the TNF-a and TNF-P level 
after the treatment and the levels of IgA, IgG, IgM, NK cell activities, 
TNF-a and TNF-p in Acanthopanax treated patients were restored to levels closer to 
that of non-cancerous subjects (Huang et al., 2005). This study hinted the possibility 
that Acanthopanax may be useful as anti-cancer drug in clinical setting too. 
1.2.3 Introduction of Grifola frondosa 
Researches about Maitake mainly focus on the effect of its polysaccharide 
extract. Intraperitoneal injection of Maitake polysaccharide extract demonstrated 
inhibitory effect on the growth of sarcoma cells SI80 in tumors and syngeneic 
systems like Meth A fibrosarcoma and MM46 carcinoma cells (Suzuki et al., 1984). 
A (1—3)-branched (1^6)-p-glucan fraction termed as D-fraction isolated from 
the fruiting body of Grifola could act as biological response modifier and activated 
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the immunity of our body. D-fraction could be prepared from Maitake fruiting body 
by boiling with water followed by ethanol precipitation and DEAE ion-exchange 
chromatography. Immune cells such as macrophages, helper and cytotoxic T cells 
would be activated by the treatment with D-fraction. Oral administration of D-fraction 
could reduce tumor size in mice without causing any severe adverse effect (Hishida et 
al., 1988). It was shown that the co-treatment of D-fraction with Mitomycin-C (MMC) 
in tumor-bearing mice not only could reduce the immunosuppression caused by MMC, 
the anti-tumor efficacy was also higher than that of MMC treatment alone. The 
treatment of D-fraction together with MMC elicited a T-helper-1 dominant response 
by inducing the IL-12 release by macrophages which would be suppressed by MMC 
treatment alone (Kodama et al., 2005b). Another in vivo study revealed that i.p. 
injection of D-fraction in MM-46 tumor bearing mice could inhibit the growth of 
tumor. The intracellular TNF-a expression of splenic NK cells as well as the amount 
of TNF-a and IFN-y released was elevated. IL-12, which plays a crucial role in 
stimulating NK cell activity, was prompted to release from both RAW 264.7 cells and 
peritoneal macrophages obtained from normal mice after the treatment with 
D-fraction. It was proposed that the tumor suppressing effect of D-fraction was 
contributed by the activation of NK cells (Kodama et al., 2002). The NK cell 
cytotoxicity towards YAC-1 cells and expression of CD223 on the surface of NK cells 
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was enhanced after D-fraction treatment. The detected IL-12 level in serum was 
elevated together with increased expression of IL-12 betal receptor on NK cells 
surface. It is suggested that the activation of macrophages and increased level of 
IL-12 were associated with the NK cells stimulatory effect of D-fraction (Kodama et 
al., 2005a). It was shown in another study that D-fraction activated the T cells, 
especially CD4+ helper T cells rather than B cells in the lymph nodes of 
tumor-bearing mice. Release of Th-1 cytokines such as IL-12 , IL-18 and IFN-y in 
spleen and lymph node were stimulated after D-fraction treatment, while Th-2 
cytokine production such as IL-ip and IL-4 were inhibited. This indicated that the 
anti-tumor activities of D-fraction may be resulted from the establishment of Th-1 
dominance immune response, which activates the cell-mediated immunity and 
cytotoxic T cells against the tumor cells (Inoue et al., 2002). 
Despite the fact that most of the researches concluded the activation of immunity 
as the cause of anti-tumor effect of Maitake, other reports revealed that direct 
cytotoxicity may also take part in the anti-tumor effect of Maitake in some cases. For 
example, a novel polysaccharide-peptide GFPSlb isolated from Maitake was reported 
to induce apoptosis in a gastric carcinoma cell line SGC-7901. Many hallmarks of 
apoptosis such as phosphatidylserine externalization, DNA fragmentation, nuclear 
condensation, activation of caspase-3 activity could be observed after the treatment 
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with the polysaccharide-peptide. Bcl-2 expression was suppressed while the Bax 
pro-apoptotic protein expression was elevated in a dose-dependent manner after the 
treatment. It is believed that GFPSlb could elicit apoptotic response in the gastric 
carcinoma cells (Cui et al., 2007). Ethyl-acetate extract from the supernatant of the 
cultured broth from submerged Grifola culture exhibited cytotoxic activities towards 
hepatoma cells including Hep G2 and Hep 3B and cervical cancer HeLa cells. Further 
fractionation and purification indicated that o-Orsellinaldehyde as the active 
component. DNA laddering was observed and obvious sub-Gl peak was formed in 
cell cycle analysis assay suggested that the tumoricidal effect of o-Orsellinaldehyde 
could be mediated through the induction of apoptosis (Lin and Liu, 2006). However, 
these reports only comprise the minority when compared with the vast number of 
investigations about the immune mediated anti-tumor effect. 
In addition, it was reported that the MD-fraction of Maitake exhibited 
anti-metastatic activity in an experimental murine model of lung metastasis. The NK 
cells activity was potentiated and IL-12 production from antigen presenting cells 
(APC) were also enhanced at the same time. B16/BL6 cell adhesion to LPS-activated 
murine lung vascular endothelial cells was inhibited by MD-Fraction. Therefore, it 
was proposed that MD-fraction would inhibit metastasis by the enhancement of NK 
cells and APC activity and suppressing the ICAM-1 so that the adhesion of tumor 
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cells to the vascular endothelial cells was hindered (Masuda et al., 2008). 
1.3. Apoptosis and Cancer 
Apoptosis or Programmed Cell Death is a way in which a cell destroys itself in a 
controlled process by eliminating vital biomolecules while maintaining cellular 
integrity. Apoptosis actually is a normal phenomenon in our body, which has its own 
physiological role. For example, it is an essential process in the development of 
multicellular organism, such as eliminating the tail of tadpole and removing the 
interdigital web of primate embryo (Meier et al., 2000). Apoptosis is also associated 
with the termination of unwanted cells in the immune system (Krammer, 2000). In 
addition, apoptosis acts as a natural ending of terminal differentiation process of 
continuously renewable cells in the epithelial surfaces and in the hematopoietic 
system (Chaturvedi et al., 1999). Other than a physiological process, apoptosis also 
acts as a self-destruction pathway for cells with severe and irreversible damage to its 
genome. This enables the conservation of the genome and prevents the accumulation 
of damaged genetic material which could be dangerous to the life of the organism 
(Miele, 2003). 
Apoptosis has drawn the attention of scientists in cancer research recently. 
Cancers are disease of un-regulated clonal expansion of cells which results in the 
invasion of normal tissue finally. The force behind cancer development is the 
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mutations in genes that govern and control the proliferation of cells. The mutations in 
such genes empower the cells to have some propagation advantages over the others, 
and as a result, the outgrowth of cells with such advantages will be fostered. 
Therefore, the genesis and progress of cancer is actually evolutionary in nature and is 
the result of natural selection of cells with such propagative advantages over the 
others (Evan and Vousden, 2001). However, it seems that our body is aware of the 
danger caused by unlimited clonal expansion of cells and has a defense system against 
such unlimited proliferation. The proliferation of cells is guarded and restrained by 
the action of apoptosis. And most of the cancer has been associated with errors in the 
apoptotic machinery which allows the propagation of cells with altered genetic 
material despite of the genomic instability, such as the overexpression of 
anti-apoptotic Bcl-2 family member (Schmitt and Lowe, 2001). The proliferation of 
transformed cells leads to the accumulation of mutations which results in the 
development of cancer eventually. 
In fact, the majority of non-surgical cancer treatment nowadays targeted at 
inducing a residual apoptotic response in the cancer cells. Radiotherapy would 
damage the DNA content of the cancerous tissues and lead to apoptosis. 
Chemotherapy aims at destroying or interfering the DNA or removing critical survival 
signals. Anti-angiogenic approach inhibits the blood vessels proliferation near tumor 
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and limits the blood supply hence the nutrients to the cancer cells and trigger 
apoptosis (Miele, 2003). A number of anti-neoplastic agents induce the synthesis of 
Fas ligand, such as doxorubicin, methotrexate, cisplatin, and bleomycin by activating 
the N F - K B pathway (Muller et al., 1997). Treatment of solid tumor with cytotoxic 
drugs such as cytarabine, 5-fluorouracil (5FU), fludarabine, cyclophosphamide, 
etoposide, and camptothecin also characterized with apoptotic features (Mesner, Jr. et 
a l , 1997). Some common anti-cancer drugs that are used in chemotherapy clinically, 
like Paclitaxel or Docetaxel and Vincristine, would also induce apoptosis of the cancer 
cells (Kaufmann and Earnshaw, 2000). 
In general, the cells in apoptosis could be characterized by a number of 
morphological features, for instance, cell shrinkage, membrane blebbing, chromatin 
condensation, formation of apoptotic bodies etc. These morphological changes 
represent a later stage of apoptosis which are the results of a series of biochemical 
events in the apoptotic cells. In other words, a number of distinctive events could also 
be observed at the molecular level (Saraste and Pulkki, 2000). Each normal cell has a 
set of genes, and therefore proteins for regulating the proliferation or committing to 
the cell suicide process. These proteins form the apoptotic machinery altogether, 
taking care of the self-destruction process step by step. The components of the 
apoptotic network are genetically encoded and considered to be usually in place in a 
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nucleated cell ready to be activated by a death inducing stimulus (Weil et al., 
1996;Ishizaki et al., 1995). Basically, apoptosis could be sub-divided into two 
pathways: intrinsic and extrinsic. Although these two pathways are activated in 
different ways, they unite at certain point and lead to the same result: the death of the 
cell. 
1.3.1 Caspases 
Caspases are a group of enzymes which play a vital role in apoptosis. They 
participate in the signal transduction process as well as the execution of the apoptotic 
pathway. The word ‘caspase，is derived from cysteine dependent aspartate protease. A 
highly conserved peptide sequence QACRG could be found in the active site of the 
caspases and the cysteine residue of the active site plays an important role in 
contributing to the proteolytic activities of caspases. Caspases are synthesized as 
inactive zymogens, which are called procaspases, with a very low basal level activity. 
Under certain appropriate condition, these procaspases could be self activated and 
then activate the procaspases downstream. Prodomain could be found in the 
N-terminal of these procaspases, followed by a large and small subunit (Earnshaw et 
al., 1999). The prodomain itself may serve a function as well, especially for 
recruitment purpose, such as the Dead Receptor Domain (DED) of procaspase-8 (Yao 
et al., 2007) or the Caspase Recruitment Domain (CARD) in the case of procaspase-9 
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(Bratton et al., 2001) . The prodomain is usually removed during the activation 
process and forms an active caspase which is a heterodimer consists of two large and 
two small subunits. Caspases could be further sub-categorized into effectors 
(caspase-3, caspase-6 and caspase-7) which are responsible for the massive 
proteolytic events or initiators (caspase-8, caspase-10, caspase-9 and caspase-2) 
which are responsible for signal transduction (Perl et al., 2005). The initiators are 
capable of autocatalytic activation while the executioners needed to be activated by 
the initiators and the interactions between those play an important role in the 
caspase-dependent apoptotic pathway (Gewies, 2003). 
1.3.2 Intrinsic apoptotic pathway 
Mitochondria play a central role in the intrinsic pathway in coordinating and 
propagating the various death signals arose within the cells. As response to different 
kinds of cellular stresses such as radiation, hypoxia, deprivation of nutrients, the 
transcription and expression of a number of apoptotic regulatory signals is attenuated, 
such as the anti-apoptotic proteins Bcl-2 and Bcl-Xi and pro-apoptotic protein Bax 
and Bak in the Bcl-2 family (Newmeyer and Ferguson-Miller, 2003). The 
pro-apoptotic proteins are involved in facilitating the opening of the voltage 
dependent ion channel in the outer membrane of mitochondria which leads to the 
depolarization of mitochondrial membrane (Tsujimoto and Shimizu, 2000). A sudden 
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increase in permeability to solute and the influx of water to mitochondria results in the 
rupture of outer mitochondrial membrane and leads to the release of cytochrome c, 
which is originally bound to the outer leaflet of inner mitochondrial membrane 
(Bemardi et al., 1999;Loeffler and Kroemer, 2000). Once released into the cytosol, 
cytochrome c would associate with Apaf-1 (Zou et al., 1997) to form a heptameric 
wheel-like structure known as apoptosome which would recruit procaspase-9 through 
its CARD domain and results in auto-activation of caspase-9 (Li et al., 1997;Acehan 
et al., 2002). As a result of caspase-9 activation, the caspase-3 would be activated and 
apoptosis would be executed. In addition to cytochrome c, other death signals would 
also be released as a result of mitochondrial permeability transition, including 
apoptosis inducing factor (AIF), endonuclease G (endoG) and Smac/DIABLO. AIF 
was associated with caspase-independent programmed cell death (Daugas et al., 2000). 
EndoG has been reported to induce CAD-independent internucleosomal DNA 
fragmentation (Schafer et al., 2004). Smac/DIABLO would bind to X-chromosome 
linked inhibitor of apoptosis (XIAP) and release caspases-3, -9 and -7 from its 
inhibition (Verhagen et al., 2000;Ekert et al., 2001). 
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Fig. 1.1 Schematic representation of intrinsic pathway of apoptosis. (adapted from 
Kaufmann, (2007)) 
1.3.3 Extrinsic apoptotic pathway 
The extrinsic apoptotic pathway is initiated by the death receptors which are cell 
surface receptors and is activated upon the binding with specific extracellular death 
inducing signals like Tumor Necrosis Factor (TNF), Fas ligand and TNFR 
apoptosis-inducing ligand (TRAIL). The death receptors belong to the tumor necrosis 
factor receptor (TNFR) gene superfamily, including TNFR-1, Fas/CD95 and the 
TRAIL receptor DR-4 and DR-5 (Ashkenazi, 2002). The cysteine rich extracellular 
domain of TNFR enables them to recognize and to bind with their specific ligands 
(Naismith and Sprang, 1998). Once Fas or TRAIL receptor is bound to its ligand, 
conformational change and oligomerization of death receptors take place and then 
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Fas-associating protein with death domain (FADD) in the cytoplasm will be recruited 
to the death domain (DD) of the cytoplasmic region of the death receptor and form a 
complex known as death inducing signaling complex (DISC). The DED domain in the 
adaptor FADD in turns recruits the DED-domain containing procaspase-8 through 
DED-DED interaction and sequesters procaspase-8 to the DISC. The localization of 
several procaspase-8 results in the autocatalytic activation and the formation of active 
caspase-8 (Budihardjo et al., 1999). If sufficient amount DISC could be formed, the 
caspase-8 may directly activate downstream caspase cascade, and this is called the 
type-1 cells (Scaffidi et al., 1998), which do not require the manipulation of 
mitochondria. In type-II cells, the activation of the death receptor activation is not 
strong enough, and only a small amount of DISC is formed. As a result, the capase-8 
activation does not create a cascade signal that is strong enough for the initiation of 
apoptosis on its own. The apoptotic signal is therefore amplified with the help from 
the mitochondria. A Bcl-2 family member Bid links the caspase signal with the 
mitochondrial pathway together. The caspase-8 cleaves Bid to its truncated form tBid. 
tBid could translocate into the mitochondrial and interact with other pro-apoptotic 
proteins Bax and Bak and results in the release of cytochrome c, Smac/DIABLO to 
cytosol and activate the intrinsic apoptotic pathway(Luo et al., 1998;Holdenrieder and 
Stieber, 2004). On the other hand, TNFR once activated will bind TNF-receptor 
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associated death domain (TRADD) instead (Hsu et al., 1995). The DD in TRADD 
will recruit other adaptor proteins such as receptor-interacting protein (RIP) and 
TNFR-associated factor II (Hsu et al., 1996). This complex will then associate with 
FADD through DD-interaction and bind with procaspase-8. However, the activation 
of T N F R would also free the N F - K B from its inhibitor and allows its translocation 
into the nucleus and results in the transcription of a series of mostly anti-apoptotic 
genes, including FLICE inhibitory protein (FLIP) (Kucharczak et al., 2003). The 
activation of TNFR would lead to apoptosis only if the transcribed survival signals are 
overwhelmed by the apoptotic response. As a tightly regulated process, other factors 
could modulate the cellular response to the death signal. For example, the presence of 
DcRl (decoy death receptor 1), DcR2, DcR3, which are not armed with functional 
dead domain, could compete for the death signals (Meng et al., 2000). They act as the 
ligand sink and prevent the activation of death receptors. Similar regulation could be 
seen in the procaspase-8 activation. c-FLIP is a homologue of procaspase-8 but 
without catalytic activity, the presence of c-FLIP interferes and limit the activation of 
procaspase-8 (Kataoka, 2005). 
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Fig. 1.2 Schematic representation of extrinsic pathway of apoptosis (Ricci and El 
Diery, (2007) 
1.3.4 Execution of Apoptosis 
Both intrinsic and extrinsic pathways lead to the activation of the effector 
caspases, and result in the observable changes in apoptotic cells. Activated caspase-3 
cleaves the actin filament severing enzyme gelsolin and contributes to cytoplasmic 
blebbing (Kothakota et al., 1997). In addition, caspase-3, together with caspase-6, 
cleaves a series of intermediate filament proteins that are important in maintaining 
normal cell shape, including lamin A, lamin B, nuclear/mitotic apparatus protein 
NuMA and cytokeratin (Fischer et al., 2003;Ruchaud et al., 2002). Other than that, 
caspase-3 also targets on ICAD (inhibitor of caspase-activated deoxyribonuclease) 
therefore releases CAD which is responsible for digesting the DNA and brings about 
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the hallmark internucleosomal DNA fragmentation (Wyllie, 1980). The proteolytic 
activity of caspase also activates a number of kinases, including protein kinase C5 
(Emoto et al., 1995), which in turn activates a phospholipid scramblase catalyzing the 
transfer of phosphatidylserine (PS) from the inner to outer leaflet of plasma 
membrane (Frasch et a l , 2000) and bring about another hallmark of apoptosis, PS 
extemalization. PS externalization has its physiological role in our body, acting as the 
signal for macrophage phagocytosis for apoptotic cells (Fadok et al., 2000). 
1.4 Cell cycle and cancer 
Apoptosis ends the cells which undergo uncontrolled proliferation and expansion 
as a result of accumulated mutations in the genome. However, if apoptosis is the 
answer to mutation in every cell, then a large number of cells would have been killed 
and that would be massacre like. In fact, DNA in every cell is under constant attack 
and susceptible to damage. For instance, free oxygen radicals from respiration could 
lead to base damage and DNA breakage. External source like sunlight or ionizing 
radiation would also lead to DNA damage. To cope with such damaging stress, our 
body has a system of DNA process although it is not perfect. To allow time for DNA 
repair, cells respond to DNA damage by pausing the cell cycle progression during the 
cell cycle checkpoint. Cell cycle checkpoint is the signal transduction pathway that 
delays cell cycle progression or induces cell cycle arrest to ensure that the previous 
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process, such as DNA replication or mitosis is completed (Hartwell and Weinert, 
1989). If the damage in DNA is too severe to be repaired, then apoptosis would take 
place to eliminate the cells with altered genetic information (Dupre and Gautier, 
2007). 
In every phase of cell cycle, there exists cell cycle checkpoints like Gl /S 
checkpoint, intra-S-phase checkpoints or G2/M checkpoint. One of the common 
features of these checkpoints is that the transcription or the activity of cyclin 
dependent kinases (cdk) would be affected. Cdks are enzymes that play a crucial role 
in regulating cell cycle progression by forming complexes periodically with proteins 
known as cyclins. The periodic expression of cyclins defines the start and transition to 
succeeding cell cycle phases (Morgan, 1997). For instance, cdk 4 and cdk 6 together 
with their D-type cyclin partners are needed for progression through G1 while cdk 2 
and cyclin E complex is required for G1 to S-phase transition. Progression through S 
phase needed the action of cdk 2 / cyclin A complex while cdk 1 and cyclin B is 
necessary for the occurrence of mitosis (Sherr, 1996). 
Under the control of cell cycle checkpoints, cells respond frequently by arrest the 
cell cycle progression or die in response to DNA damage and the risk of cancer 
development will be lowered. However, mutations in the signal transduction pathway 
of cell cycle checkpoints would allow the survival or progression of cells with 
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genomic abnormalities and the likelihood of malignancies development will be much 
more enhanced (Kastan and Bartek, 2004). Therefore, if a compound could inhibit the 
activity of cdk or alter the expression of cyclins in tumor cells, the cell cycle may 
once again halted and stop the cancer development. Specific inhibitors of cdk, such as 
inhibitors of cdk 4 or cdk 6 could block the cells from progressing into S phase, as a 
result promoting cell cycle arrest or even lead to apoptosis in cancer cells (Weinberg, 
1995). 
1.5 Objective of this project: 
The present study aims at investigating the anti-tumor effect of Acanthopanax on the 
human breast cancer cell lines MCF-7 and MDA-MB-231, and human hepatoma Hep 
G2 cells. The active fraction responsible for such activities will be studied and the 
mechanism behind the anti-tumor effect will also be addressed. 
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Chapter 2 Materials and Methods 
2. m a t e r i a l s 
2.1.1. Culture medium 
Fetal bovine serum (FBS) and Penicillin-Streptomycin (PS) 
FBS and PS were purchased from GIBCO Invitrogen (Grand Island, NY, USA). The 
FBS was subjected to heat inactivation by incubating at 56 °C for 30 minutes before 
use. FBS and PS were stored at - 2 0 X：. 
RPMI 1640 
RPMI (Rosewell Park Memorial Institute) 1640 powder containing phenol red, 
L-glutamine and 0.5 mM HEPES were purchased from GIBCO Invitrogen (Grand 
Island, NY, USA). 16.4 g of RPMI 1640 powder and 2 g of sodium bicarbonate were 
dissolved into 1 L of distilled water. The pH of the medium was adjusted to 7.2 with 
the addition of NaOH or HCl while stirring. Membrane filtration was performed with 
the use of 0.22 f^m cellulose acetate membrane bottle-top filter and the filtered 
medium was stored at 4 ()C. 
DMEM 
DMEM (Dulbecco's Modified Eagle's Medium) powder containing phenol red, 
D-glucose, L-glutamine and sodium pyruvate were purchased from GIBCO 
Invitrogen (Grand Island, NY, USA). 13.4 g of DMEM powder and 3.7 g of sodium 
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bicarbonate were dissolved in 1 ml of distilled water. The pH was adjusted to 7.2 with 
the addition of HCl or NaOH while stirring. Membrane filtration was performed with 
the use of 0.22 |am cellulose acetate membrane bottle-top filter and the filtered 
medium was stored at 
2.1.2 Buffers and reagents 
MTT 
MTT was purchased from Sigma (St. Louis, MO, USA). MTT solution was prepared 
by dissolving 50 mg MTT powder in 5 ml PBS. 
XTT 
XTT and PMS (Phenazine methosulfate) was purchased from Sigma (St. Louis, MO, 
USA). XTT solution was prepared by dissolving 15 mg of XTT powder into 50 ml of 
PBS. XTT solutions were kept in darkness in 4 °C while PMS was kept at darkness in 
-20 OC. 
PBS 
The composition of PBS (Phosphate-buffered Saline) was 2.7 mM KCl, 1.5 mM 
KH2PO4，136 mM NaCl and 8 mM Na2P04. The pH was adjusted to 7.4 and sterilized 
by autoclave and then stored at room temperature. 
Flow cytometry 
JC-1 and propidium-iodide were prepared by dissolving in DMSO and were stored at 
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-20 ^C. These stock solutions are at least 1000 times more concentrated than the 
working concentration so that the influence of DMSO on the assay should be 
negligible. 
Propidium-iodide (PI) was purchased from Sigma (St. Louis, MO, USA). PI powder 
was dissolved in distilled water at a concentration of 2 mg/ml for cell cycle analysis 
or at a concentration of 1 mg/ml for Annexin-V-PI labeling. 
Annexin-V-FITC staining solution was purchased from BD Biosciences Pharmingen. 
AV-PI staining buffer was prepared by 10 mM HEPES, 140 mM NaCl and 5 mM 
CaCb and the pH was adjusted to 7.4. 
DNA fragmentation 
Reagents and chemicals being used in the DNA fragmentation experiment were listed 
in the Table 2.1 below. DNA 6 X loading dye and 100 base pair DNA marker was 
purchased from Fermentas (EU). Agarose was purchased from United States 
Biochemical Corporation (Cleveland, OH, USA). 
Table 2.1 Reagents and buffers used in DNA fragmentation 
Reagent / Buffer Constituents and Concentration Storage 
DNA lysis buffer 50 mM Tris-HCl Room temperature 
20 mM EDTA 
3 % (v/v) IGEPAL CA-630 
((Octylphenoxy)polyethoxyethanol) 
pH adjusted to 7.5 
RNase A 10 mg/ml dissolved in dH20 -20 ()C 
Proteinase K 20 mg/ml dissolved in dH20 -20 ^C 
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TE buffer 10 mM Tris-HCl Room temperature 
0.1 mM EDTA 
pH adjusted to 7.5 
5OX 2 M Tris base Room temperature 
Tris-Acetate-EDTA 57.1 ml Glacial Acid 
(TAE) buffer, 1 L 0.5 M EDTA 
pH adjusted to 8.0 
Western blotting 
Reagents and buffers used in Western blotting experiment were listed in the Table 2.2 
below. The antibodies against Bcl-2, procaspase-3 and PARP were purchased from 
Santa Cruz Biotechnology, Inc. Antibodies against procaspase-9 and caspase-9 were 
purchased from StressGene Biotechnology Corp. while the antibodies for cdk 2, 
Cyclin D] and p-actin were purchased from Cell Signaling Technology, Abeam pic 
and Sigma respectively. 
Table 2.2 Reagents and buffers used in Western blotting 
Reagent / Buffer Constituents and Concentration Storage 
0.0625 M Tris-HCl 
Total protein extraction 2 % (w/v) SDS ^ � ^ 
lysis buffer 10 % Glycerol 
pH adjusted to 6.8 
90.8 g Tris base 
4 X Separating gel buffer ^ ^ ^ ^ 4 o^ 
(500 ml) T ! � . � " 
^ ， pH adjusted to 8.8 
30.3 g Tris base 
4 X Stacking gel buffer ^ ^ ^ ^ 4 � � 
(500 ml) T ， � . � ， � 
， pH adjusted to 6.8 
30.3 g Tris base 
10 X SDS running buffer ^ . 
144 g Olycine 
(1 L) 10，SDS Room temperature 
10 X Tris-Buffered Saline 12.11 g Tris base Room temperature 
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(TBS),(1 L) 87.66 g NaCl 
pH adjusted to 8.0 
T D d I X TBS 
1 1 Room temperature 
1 ml Tween-20 
30.3 g Tris base 
10 X Tris-glycine 144 g Glycine Room temperature 
pH adjusted to 8.3 
5.82 g of Tris base 
2.93 g of glycine 
Electroblotting buffer (1L) 1.875 ml of 20% SDS Room temperature 
200 ml of methanol 
pH adjusted to 9.2 - 9.4 
Separating gel (12%) was freshly prepared right before electrophoresis. It was 
composed with 40 % acrylamide / bis-acrylamide (30 %) solution (BIO-RAD 
Laboratories), 25 % 4 X separating gel buffer, 0.05 % (w/v) ammonium persulphate 
(APS) (BIO-RAD Laboratories) and 0.12 % TEMED (BIO-RAD Laboratories). 
Stacking gel (4.5%) was freshly prepared right before electrophoresis. It was 
composed of 15 % acrylamide / bis-acrylamide (30 %) solution, 25 % 4 X stacking 
gel buffer, 0.05 % (w/v) ammonium persulphate (APS) and 0.12 % TEMED. 
2.1.3 Herbs 
The dried root of Astragalus memhranaceus (voucher no. 2005-273 lb) was purchased 
from Inner Mongolia. Dried cortex of Acanthopanax senticosus (voucher no. 
2005-2780) was purchased from Jilin. Dried fruiting body of Grifola frondosa was 
purchased from northern Guangdong (2005-2758). 
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2.2 Methods 
2.2.1 Cell Cultures 
2.2.1.1 Cell lines 
Four cell lines, Hep G2, Hs68, MCF-7 and MDA-MB-231, were employed in 
this study. All of them were purchased from American Type Culture Collection 
(ATCC). Hep G2 is a human hepatocellular cell line (ATCC no. HB-8065) which does 
not contain a Hepatitis B virus genome. MCF-7 (ATCC no. HTB-22) is an 
estrogen-responsive breast cancer cell line, which simulates a relatively early stage of 
breast cancer. On the other hand, MDA-MB-231 (ATCC no. HTB-26) is a breast 
cancer cell line which does not express estrogen receptors, and represents a latter and 
more invasive stage of breast cancer. All of these three cell lines are adherent in nature, 
and were maintained in RPMI 1640 medium supplemented with 10% (v/v) heat 
inactivated fetal bovine serum and 1% (v/v) penicillin-streptomycin (complete 
medium) at 37°C and 5% CO2 humidified atmosphere. 
Hs68 (ATCC no. CRL-1635) is a normal foreskin fibroblast cell line, which is 
obtained from an apparently normal Caucasian newborn male. This cell line is also 
adherent in nature, and it was maintained in DMEM medium, supplemented with 10% 
(v/v) heat inactivated fetal bovine serum and 1% (v/v) penicillin-streptomycin 
(complete medium) at Y f C and 5% CO2 humidified atmosphere. 
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2.2.1.2 Cell culture techniques 
The cells were cultivated in T75 culture flask with 10 ml complete medium. 
Subculture was performed when 70-80% confluence of 丁75 was reached. Hep G2, 
MCF-7, and MDA-MB-231 cells were subcultured every 3-4 days, while Hs68 cells 
were passed every 7-8 days. The used medium was discarded and the bottom of the 
flask was rinsed by PBS to remove any remaining medium. The cells were brought 
into suspension by the use of trypsin/EDTA solutions. Centrifugation was carried out 
at 375 xg for 3 minutes after the addition of complete medium. The cell pellets were 
then resuspended with complete medium and passed to a new culture flask. 
2.2.1.3 Cryopreservation of cell lines 
Frozen cell culture stock was kept in cell tank filled with liquid nitrogen for long 
term storage. Cells were brought into suspension by EDTA/trypsin, after washing 
with PBS. After centrifugation at 375 xg, the cell pellet was resuspended with 4 ml of 
fresh complete medium. The number of viable cells was determined by trypan blue 
exclusion test with a hemocytometer. 3 x 10*^  cells were resuspended in 1 ml of 
freezing medium consisted of 50% FBS (v/v), 40% complete medium and 10% 
DMSO (v/v). The cells were then transferred to a cryogenic vial (Nalgene, USA) and 
stored at -70 ()C overnight. The cells were then kept frozen in liquid nitrogen for 
future use. 
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Frozen cell lines could be resuscitated by thawing the cells in 37 water bath 
until a small amount of ice remained in the vial. Thawed cells were resuspended by 10 
ml pre-warmed complete medium and were then incubated in a T75 flask in 37 ""C with 
humidified atmosphere of 5% CO2 for 24 hours. The culture medium was replaced 
with fresh complete medium on the next day. 
2.2.2 Proliferation assay 
2.2.2.1 MTT assay 
MTT assay was used to determine the proliferation of cells treated with the 
herbal extracts. MTT [3-(4,5-dimethylthiazolyl)-2,5-diphenyl-tetrazolium bromide, 
Sigma] would be reduced to purple formazan salt by the action of mitochondrial 
dehydrogenase found in living cells. The formation of the formazan salt could be 
monitored spectrophotometrically by measuring the absorbance at 540 nm. 
Cells were harvested from the culture flask as described previously. The amount 
of viable cells was determined by the trypan blue exclusion test with the use of 
hemocytometer. For Hep G2, MCF-7 and MDA-MB-231, 5,000 cells were seeded in 
100 |il of complete medium in each well of 96-well flat bottom culture plates (Iwaki, 
Japan), while 7000 Hs68 cells were seeded in each well of the 96-well flat bottom 
culture plates. The cells were incubated in 37 "C humidified atmosphere of 5 % CO2 
for 24 hours to allow time for the adherence of cell to the bottom of the well. 
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Complete medium containing various concentrations of herbal extracts were added to 
the well accordingly and the cells were further incubated in 37 ^C humidified 
atmosphere of 5 % CO2 for 48 hours. 
After 48 hours of incubation, the culture medium was replaced by fresh complete 
medium and then 30 |il of 5 mg/ml MTT solution were added to each well. After 2 
hour 37 ^C incubation, the culture medium was again aspirated and the formazan 
product was dissolved by the addition of 100 )il DMSO. Absorbance at 540 nm was 
then measured by BMG FLUOstarOptima microplate reader (BMG LABTECH 
GmbH, Offenburg, Germany). The results were expressed as the percentage of 
absorbance at 540 nm of the vehicle control. 
2.2.2.2 Isolation of PBMC 
Buffy coat provided by the Hong Kong Red Cross was diluted with PBS in a 
ratio of 1 : 1. 20 ml diluted buffy coat was carefully pipetted onto an equal volume of 
Ficoll-Paque 丁^  plus solution (GE healthcare, UK) in a 50 ml centrifuge tube so that 
two layers were formed. Centrifugation was carried out at 800 xg for 20 minutes at 18 
Three layers could be found after the centrifugation, plasma formed the top layer, 
while PBMC were located in the middle layer and the bottom layer was Ficoll-Paque 
TM Plus solution and red blood cells. PBMC were then aspirated out with care and 
washed with PBS twice followed by centrifugation at 100 xg for 10 minutes at 18 ''C. 
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The cell pellet was resuspended in 4 ml of complete RPMI medium and trypan blue 
exclusion test was performed to check the number of viable cells. The PBMC was 
then seeded into 96-well flat bottom culture plates (Iwaki, Japan) in a density of 4 x 
10^ per well. Since PBMC are cells in suspension, the proliferation of PBMC is 
monitored by the use of XTT instead of MTT. 
2.2.2.3 XTT 
After 48 hours of treatment with herbal extracts, the proliferation of PBMC was 
determined with the use of XTT assay. Active XTT reagent (sodium 3 ' - [ l -
(phenylaminocarbonyl)- 3,4- tetrazolium]-bis (4-methoxy- 6-nitro) benzene sulfonic 
acid hydrate) was prepared by mixing 300 |ag/ml XTT in PBS with PMS in a ratio of 
400 : 1. 50 ml of active XTT reagent was added to each well. After 4 hours of 
incubation at 37 proliferation of PBMC could be verified by measuring 
absorbance at 450 nm with a microplate-reader. 
2.2.3 DNA fragmentation 
As one of the hallmarks of apoptosis, DNA fragmentation assay was carried out 
to confirm the apoptotic effect of Acanthopanax extract on breast cancer cells. MCF-7 
and MDA-MB-231 cells were seeded on a 100 n W culture dish (Iwaki, Japan) at a 
density of 1 x 10^ cells/ml. 24 hour incubation at 37 with humidified atmosphere of 
5 % CO2 was allowed for the adherece of the cells to the bottom of the dish and the 
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culture media was then replaced by complete RPMI medium containing various 
concentrations of Acanthopanax extract. After 48 hours of treatment, the culture 
medium together with the floating cells were collected and adherent cells were 
harvested with EDTA/trypsin treatment. The collected cells were then centrifuged at 
800 xg for 3 minutes and the cell pellet was washed twice with PBS followed by 
centrifugation at 800 xg for 3 minutes. The cell pellet was then subject to 200 |li1 of 
lysis buffer and incubated at 37 for 15 minutes. The lysed cells were then 
centrifuged at 6000 xg for 5 minutes and the DNA-containing supernatant was 
transferred to a microcentrifuge tube containing 50 |il of 5% SDS solution and stored 
at 4 until use. 
10 |Lil of 10 mg/ml RNase A solution was added to each microcentrifuge tube and 
incubated at 56 for 90 minutes in order to digest the cellular RNA. Then, 20 |al of 
10 mg/ml Proteinase K solution was added and incubated for another 90 minutes to 
remove the protein debris in the samples. DNA in the samples was precipitated by the 
addition of 30 |li1 of 3 M sodium acetate solution and 750 ml of absolute ethanol, 
followed by centrifugation at 20,000 xg for 30 minutes. The supernatant was 
discarded and the DNA precipitate was washed with 1 ml of 75 % ethanol and 
absolute ethanol, followed by centrifugation at 20,000 xg for 5 minutes. Supernatant 
was again discarded and the DNA pellet was air-dried. 30 ml of TE buffer was then 
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added to each DNA sample and incubated at 37 ()C for 30 minutes. DNA extracted 
was then added to a 1.5 % (w/v) agarose gel with 0.5 mg/ml Ethidium Bromide 
incorporated. Electrophoresis was then carried out at a constant voltage of 100 V for 
about 45 minutes and the DNA bands were visualized under ultraviolet illumination. 
2.2.4 Flow cytometry 
Cells with appropriate treatment were subjected to the analysis of flow cytometer 
system FACS CANTO II (Becton Dickinson). For every set of experiment, forward 
scatter (FSC) and side scatter (SSC) were used to identify and gate the target cell 
population by their size and granularity. 10,000 events of desired cell population were 
collected for each sample. WinMDI version 2.9 was employed to analyze the data 
collected from flow cytometry. 
2.2.4.1 Detection of mitochondrial membrane depolarization by the use of JC-1 
MCF-7 and MDA-MB-231 cells were seeded in a 6-well culture plate (Iwaki, 
Japan) in a density of 2 x 10^ per well and incubated for 24 hours for the adherence of 
the cells. The culture media were then replaced by RPMI complete medium with 
various concentrations of Acanthopanax extracts. After 48 hours of treatment, both 
floating and attached cells were collected and were centrifuged at 800 xg for 3 
minutes. The cell pellets were resuspended and washed for two times with PBS, 
followed by centrifugation at 800 xg for 3 minutes. The cells were then resuspended 
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with JC-1 solution, containing 1 |li1 of JC-1 and 500 of PBS. After incubation at 37 
•C for 15 minutes, the cells were subjected to flow cytometric analysis with an 
excitation at 488 nm. Fluorescence signal FITC and PE channels were collected for 
the detection of mitochondrial membrane depolarization. 
2.2.4.2 Annexin-V-FITC PI labeling of apoptotic cells 
One of the earliest features of apoptosis is the translocation of phosphatidylserine 
(PS) from the inner to the outer leaflet of the cell membrane. And the externalization 
of PS molecules could be characterized with double staining with Annexin-V-FITC 
and PL 
MCF-7 and MDA-MB-231 cells at a density of 2 x 10^ per well were seeded in a 
6-well culture plate (Iwaki, Japan) and incubated at 37 humidified atmosphere of 5 
o/o CO2 for 24 hours for the adherence of cells. The culture media were then replaced 
by complete RPMI medium containing various concentrations of Acanthopanax 
extracts. After 48 hours of treatment, both floating and attached cells were collected 
and centrifuged at 800 xg for 3 minutes. Cell pellets were resuspended and washed 
with PBS for two times, followed by centrifugation at 800 xg for 3 minutes. The cell 
pellets were resuspended with the AV-PI staining solution and incubated at room 
temperature and in darkness for 15 minutes. The cells were then subjected to flow 
cytometric analysis with an excitation at 488 nm. Fluorescence signals in FITC and 
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Per-CP Cys-5 channels were gathered for characterizing apoptotic cell population. 
2.2.4.3 Cell cycle analysis 
MCF-7 and MDA-MB-231 cells were seeded in 6-well culture plates (Iwaki, 
Japan) at a density of 2 x 10^ per well. After incubating at 37 with humidified 
atmosphere of 5 % CO2 for 24 hours, the culture media were replaced by RPMI 
complete medium containing various concentrations of Acanthopanax extracts. After 
48 hours of treatment, both the floating and attached cells were collected and 
centrifuged at 800 xg for 3 minutes. The cells were then washed twice with PBS, 
followed by centrifugation at 800 xg for 3 minutes. The cell pellets were then fixed 
with 1 ml of 70 % ethanol at 4 ()C overnight. Propidium-iodide staining solutions 
containing 43 [ig/m\ propidium-iodide dye and 1 mg/ml RNase A in PBS were freshly 
prepared before the assay. Fixed cells were centrifuged at 800 xg for 3 minutes and 
the cell pellets were resuspended in 460 jil of propidium-iodide staining solution and 
incubated at 37 °C in darkness for 30 minutes. The cells were then subjected to flow 
cytometric analysis with an excitation at 488 nm. Fluorescence signals in the PI 
channel were collected. 
2.2.5 Western blotting 
2 X 106 MCF-7 and MDA-MB-231 cells were seeded in 100 mm^ culture dish 
(Iwaki, Japan) and incubated for 24 hours for cell adherence. Culture media were then 
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replaced by complete RPMI medium containing various concentrations of 
Acanthopanax extracts, and incubated for 48 hours. 
2.2.5.1 Total protein extraction 
After 48 hours of treatment, medium together with floating cells were aspirated 
and attached cells were harvested by adding 1 ml of EDTA/trypsin solution. Floating 
and attached cells were then pooled and centrifuged at 800 xg for 3 minutes. The cell 
pellets were then washed with PBS for two times, followed by centrifugation at 800 
xg for 3 minutes. The cell number was then determined by the use of hemocytometer. 
For every one-million of cells, 100 ml of lysis buffer were added and incubated at 
room temperature for 30 minutes. The lysed cells were then boiled at 100°C for 10 
minutes, followed by centrifugation at 20,812 xg for 7 minutes. Protein containing 
supernatants were then collected and stored at -20 ^C until use. 
2.2.5.2 Determining protein concentration 
The protein concentrations in the cell lysates were determined colorimetrically 
by Bicinchoninic acid (BCA) assay. Protein samples were ten-fold diluted by mixing 
1 ml of protein samples with 9 ml PBS in a 96-well culture plate. 200 ml of BCA 
reaction mixture, which consisted of a mixture of BCA solution and CUSO4 • 5H2O in 
a ratio of 50 : 1, were added to each protein sample. Triplicates were performed for 
each protein sample to ensure an accurate result. After incubating at 37 ()C for 30 
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minutes, absorbance at 540 nm was measured with a microplate reader. Bovine serum 
albumin (BSA) was employed as a protein standard to construct a standard curve with 
protein concentration ranged from 0 - 1 0 mg/ml. Protein concentrations in the cell 
lysates were calculated by referring to the standard curve. 
2.2.53 SDS-PAGE 
Mini-Protean 3 cell (BIO-RAD Laboratories) was employed in the experiments. 
SDS-PAGE was set up according to protocol stated in the user manual, with 4.5 % 
stacking gel and 12.5% separating gel used. 25 jug of protein was mixed with an equal 
volume of 2X loading gel containing SDS and p-mercaptoethanol and the protein 
samples were denatured by 3-minute boiling. Protein samples and low range protein 
marker were then loaded into the wells. Electrophoresis was performed at a constant 
voltage of 120 V for about 90 minutes. The stacking gel was then cut out and soaked 
in the transfer buffer for equilibration. 
2.2.5.4 Electroblotting 
Trans-Blot SD^ Electrophoretic Transfer Cell (BIO-RAD Laboratories) was 
used in electroblotting. A 0.22 jiim PVDF (polyvinylidene fluoride) membrane was 
soaked in the transfer buffer for 15 minutes to ensure complete wetting before 
electroblotting. Two extra-thick filter papers were also saturated with transfer buffer 
by soaking for 15 minutes. The transfer system is set up by aligning materials onto the 
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platinum anode as the following sequence: cathode, pre-soaked extra thick filter paper, 
PVDF membrane, polyacrylamide gel, pre-soaked extra-thick filter paper, anode. Air 
bubbles in-between the various layers were carefully excluded by slowly rolling a test 
tube over the transfer sandwich. Electroblotting was then performed at a voltage of 15 
V for about 30 minutes. 
2.2.5.5 Probing 
After electroblotting, the PVDF membrane was soaked in 10 ml of 5% non-fat 
milk (TBS-T) for 2 hours at room temperature for non-specific blocking. The 
membrane was then probed with primary antibody at specific dilutions with non-fat 
milk at 4 overnight. After washing with TBS-T for three times for 15 minutes, 
secondary antibody was added and incubated for an hour at room temperature. The 
membrane was again washed with TBS-T twice for 15 minutes to remove the 
unbound antibodies and the membrane was ready for enhanced chemiluminescence 
assay. 
2.2.5.6 ECL 
The PVDF membrane was treated with 1 ml of ECL reagent (Amersham 
Pharmarcia Biotech) prepared by mixing ECL reagent 1 and ECL reagent 2 at a ratio 
of 1 : 1. After 3 minutes of reaction, the fluorescent signal could be detected by 
exposing the membrane to a Fuji Medical x-ray film (super Rx, Fuji) for various time 
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intervals. The x-ray film was then developed by a film processor (M35 X-MOAT, 
Kodak). 
2.2.6 Preparation of herbal extracts 
2.2.6.1 Preparation of extract of Astragalus memhranaceus and Grifola frondosa 
About 100 g of herbs were extracted by boiling at 100 under reflux with 1 L 
of different solvents (distilled water, 50 % and 95 % ethanol) for an hour twice by an 
electric heat mantle. The extracts were then centrifuged at 1000 xg for 10 minutes and 
the supematants were frozen at -70 overnight. The frozen extracts were treated 
with liquid nitrogen before subjecting to lyophilization and then were stored in a 
dessicator. 
2.2.6.2 Preparation of Acanthopanax senticosus aqueous extract 
About lOOg of Acanthopanax was extracted by boiling at 100 under reflux 
with distilled water for an hour twice by an electric heat mantle. The extract was then 
centrifuged at 1000 xg for 10 minutes to precipitate the non-soluble materials. The 
supernatant was then frozen at -70 ()C overnight. The frozen extract was treated with 
liquid nitrogen before subjecting to lyophilization and then was stored in a dessicator. 
2.2.6.3 Partition of Acanthopanax 
Acanthopanax was first grated by razor blade and then was soaked in methanol 
for six days. The methanol extract was subjected to rotary evaporator and the residue 
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was re-dissolved in distilled water. The water fraction was then partitioned with 
n-hexane in a separating funnel. The two solvents were mixed mildly to prevent 
emulsification. The partition system was left undisturbed until the formation of two 
distinct layers again. The hexane layer was then collected and replaced by fresh 
hexane. This process is repeated until the hexane layer remains colorless at the end of 
partition. 
The water layer was then subsequently partitioned with three other organic 
solvents in the order of chloroform, ethyl-acetate and water-saturated n-butanol as 
described previously. The organic solvent extracts were treated with sodium carbonate 
and then filtered to remove the water contaminants. Filtered extracts then were 
subjected to rotary evaporator. And the residues were kept in the vacuum chamber for 
48 hours to ensure the removal of all of the solvents. The dry mass of the partition 
extracts were then weighed. 
2.2.6.4 Column purification of ethyl-acetate fraction 
About 4 g of ethyl-acetate fraction was applied onto 400 g of silica gel column 
chromatography ( s i z e � 4 . 8 cm x 4.8 cm x 50 cm). A discontinuous gradient elution at 
a flow rate of 6 ml/min was performed with a mobile phase of hexane and 
ethyl-acetate. 1.5 L of 5 : 3 of hexane and ethyl-acetate, then 1 L of 10 : 9 hexane and 
ethyl-acetate, followed by 2 L of 2 : 5 hexane and ethyl-acetate. Then the column was 
48 
eluted with 1 L of ethyl-acetate. Finally, 3 L methanol was applied to the column. The 
eluates were collected by a fraction collector and elutes with similar chemical profile 
were pooled together to generate a sub-fraction. 
2.2.6.5 Analytical thin layer chromatography 
Chemical constituents in various extracts from Acanthopanax were revealed by 
performing thin layer chromatography (TLC). Silica gel 60 F254 on aluminum sheet 
(20 X 10 cm, MERCK, Darmstadt, Germany) was employed as the stationary phase in 
TLC study. A solvent system consisted of hexane, ethyl-acetate and formic acid at a 
ratio of 5 : 3 : 0.05 was employed as the mobile phase. Isofraxidin was used as the 
reference compound, as suggested in the Pharmacopoeia of the People's Republic of 
China (2005). Glass chamber was pre-equilibrated with the mobile phase for 15 
minutes in order to create a closed environment saturated with the mobile phase. The 
TLC plate was then placed into the chamber. The TLC plate was then allowed to dry 
out in a well ventilated area after development. The bands were observed at three 
different conditions, UV longwave (365 nm), UV shortwave (254 nm) and spraying 
with 10 o/o (v/v) sulphuric acid in 95 % ethanol and heated to 110 ()C for 2 minutes and 
viewed under visible light. All the solvents used including 仏hexane, chloroform, 
ethyl-acetate, ^-butanol, formic acid and methanol were analytical reagents and were 
purchased from LAB-SCAN (Thailand). 
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2.2.7 Statistical Analysis 
Results of the assays were expressed as mean 土 S.D. Statistical significance was 
determined by Student's unpaired t-test. Difference with a p value less than 0.05 would 
be considered as statistical significant. 
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Chapter 3 Results 
3.1 Extractions 
Components of Astragalus and Maitake were extracted with distilled water, 50 % 
ethanol or 95 % ethanol while compounds of Acanthopanax were extracted by reflux 
with distilled water for 2 hours only. The yield in terms of weight for the three herbs 
after extraction was listed in Table 3.1. 
Table 3.1 Extraction yield of Astragalus, Maitake and Acanthopanax 
Astragalus Maitake Acanthopanax 
Solvent 
Percentage Yield 
Water 36.67% 36.8% 10.9% 
50 % EtOH 22.8% 9.45% / 
95 % EtOH 16.6% 8.7% / 
The herbs were refluxed with the solvents for 2 hours. The percentage yield was 
calculated by dividing the dry mass of the extract by the mass of raw herb used (lOOg) 
3.2 Anti-proliferative effect of herbal extracts on cancer cell lines 
The effects of the Astraglus extracts on the proliferation of various cancer cell lines 
were studied with MTT assay (Fig. 3.1). The aqueous, 50 % ethanol and 95 % ethanol 
extracts did not show any statistically significant inhibition on the growth of the three 
tested cell lines at a concentration up to 800 \ig/m\ (Fig. 3.1). 
The results of MTT test of Maitake extracts were shown in Fig. 3.2. Similarly, the 
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aqueous, 50 % ethanol and 95 % ethanol extracts did not show any statistically 
significant inhibition on the growth of the three tested cancer cell lines at a 
concentration up to 800 )ag/ml. 
The results of of MTT assay with the Acanthopanax water extract were shown in Fig. 
3.3. The aqueous extract exhibited suppressive effect on the growth of MCF-7, 
MDA-MD-231 and Hep G2 cells in a dose-dependent manner. Statistically significant 
inhibitory effect could be observed from a concentration of 300 to 800 ^ig/ml. As can 
be seen, MCF-7 and MDA-MB-231 were the most susceptible cell lines. On the other 
hand, the Acanthopanax water extract also demonstrated a dose-dependent inhibitory 
effect on the growth of Hs68 human normal skin fibroblast cell line. Yet, the 
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Fig. 3.1 Effect of Astragalus aqueous (A), 50 % EtOH (B), 95 % EtOH (C) extracts on the 
proliferation of MCF-7, MDA-MB-231 and Hep G2 cells. Cells in a density of 5 x 10' / 
ml were treated with various concentrations of Astragalus extracts for 48 hours at 37 "C, 
5 o/o CO2. Cell viability was then determined by MTT assay. Results were expressed as 
percentage of absorbance with respect to control (100%). Results are mean 土 S.D. of 3 
determinations. 
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Fig. 3.2 Effect of Maitake aqueous (A), 50 % EtOH (B), 95 % EtOH (C) extracts on the 
proliferation of MCF-7, MDA-MB-231 and Hep G2 cells. Cells in a density of 5 x 10’ / 
ml were treated with various concentrations of Maitake extracts for 48 hours at 37 5 
% CO2. Cell viability was then determined by MTT assay. Results were expressed as 
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Fig. 3.3 Effect of Acanthopanax aqueous extract on the proliferation of MCF-7, 
MDA-MB-231, Hep G2 and Hs68 cells. Cells in a density of 5 x 10^ / ml (MCF-7, 
MDA-MB-231 and Hep G2) or 7 x l O V m l (Hs68) were seeded in 96-well plate and 
incubated at 37 5 % CO2 overnight. The cells were then treated with various 
concentrations of Acanthopanax aqueous extract for 48 hours. Cell viability was then 
determined by MTT assay. Results were expressed as percentage of absorbance with 
respect to control (100%). Results are mean 士 S.D. of 3 determinations. Difference 
between extract treated and control was determined by Student's unpaired t-test. *p < 
0.05 for MCF-7, #p < 0.05 for MDA-MD-231, +p < 0.05 for Hep G2 cells and ^p < 
0.05 for Hs68 cells. 
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3.3 Partition of Acanthopanax methanol extract 
The Acanthopanax was treated with methanol for six days at room temperature and 
the methanol extract was further partitioned with four organic solvents in a sequence 
of ^-hexane, chloroform, ethyl-acetate and ^-butanol. The yield of the partition was 
shown in Table 3.2 and the chemical profiles of the partition fractions were studied by 
TLC. Three conditions were used to reveal the bands on the TLC plate. The TLC 
plates were viewed under UV at 365 nm to elicit the natural fluorescence of 
compounds. Besides, since the silica gel plate that we used would emit fluorescence 
under illumination of UV at 254 nm, compounds that absorb UV at 254 nm would 
therefore appear as dark spots on a bright green background. This method is known as 
fluorescence quenching. In addition, sulfuric acid was sprayed over the TLC plate and 
used as a universal reagent to help visualizing compounds including glycosides, 
flavonoids, steroids, triterpenes etc. The chromatographs were shown in Fig. 3.4. It 
could be observed in the chromatographs that the bands are localized on the upper 
part of the plate in less polar fraction like hexane fraction while bands could only be 
found in the lower part of the plate in the butanol fraction. However, overlapping of 
the bands could be seen among the four fractions. 
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Table 3.2 Partition yield of Acanthopanax 
Solvent Weight (g) Percentage yield (w/w) 
Methanol 85.78 9.03 % 
Hexane 11.69 13.63 % 
Chloroform 2.25 2.62 % 
Ethyl-acetate 8.39 9.78 % 
…butanol 14.21 16.57% 
The methanol extract of Acanthopanax was partitioned with hexane, chloroform, 
ethyl-acetate and butanol. The yield of methanol extract was calculated by dividing 
the dry mass of the fraction by the mass of the raw herb used in partition (950g) while 
the partition yield was calculated by dividing the dry mass of the fraction by the mass 



















































































3.4 Anti-proliferative effect of Acanthopanax partition fractions on breast cancer cells 
The effects of the partition fractions on the growth of breast cancer cell lines MCF-7 
and MDA-MB-231 cells were investigated with MTT assay. The results were shown 
in Fig. 3.5 and Fig. 3.6. All four fractions showed anti-proliferative effects on both 
breast cancer cell lines though with different potency. Both chloroform and 
ethyl-acetate fractions exhibited statistically significant anti-proliferative effect on 
MCF-7 and MDA-MB-231 cells, starting from a concentration of 50 jig/ml to 200 
|Lig/ml. For hexane fraction, statistically significant inhibitory effect on MCF-7 cells 
growth was observed at a concentration start from 50 jig/ml onwards while such 
significant inhibitory effect on MDA-MB-231 cells growth could only be seen at a 
concentration higher than 100 }ig/mL For butanol fraction, statistically significant 
anti-proliferative effect on MCF-7 and MDA-MB-231 cells was not noted until the 
concentration reached 150 )Lig/ml. 
3.5 Column chromatography of ethvl-acetate fraction 
The ethyl-acetate fraction was further purified by employing column chromatography 
of silica gel. Discontinuous gradient elution was performed. Analytical TLC was 
employed for investigating the chemical profiles of the eluents. Eluents of similar 
profiles were pooled together as a sub-fraction. The TLC chromatographs of the 
sub-fractions were shown in Fig. 3.7. It can be observed that compounds of different 
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polarities were separated and localized in different sub-fractions and the overlapping 
of the bands was less extensive when compared with that in partition. The yields of 
the sub-fractions were listed in Table 3.3. 
Table 3.3 Yield of sub-fractions of column chromatography 
Fractions Yield (mg) Percentage Yield (%) 
Fa 182 ^ 
Fb 183 4.575 
Fc 262 ^ 
¥d 93 
Fe 183 4.575 
Ff m 3A 
Fg 3]A 
Fh 
Fi 2255 56.375 — 
Ethyl-acetate fraction of Acanthopanax was further purified by silica gel column 
chromatography. Elutes with similar chemical profiles were pooled together as a 
sub-fraction. The percentage yield of various sub-fractions was calculated by dividing 
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Fig. 3.5 Effect of partition extract (A) Hexane; (B) Chloroform on the proliferation of 
MCF-7 and MDA-MB-231 cells. Cells in a density of 5 x 1 0 ” ml were seeded in 
96-well plate and incubated at 37 ""C, 5 % CO2 overnight. The cells were then treated 
with various concentrations of partition fractions for 48 hours. Cell viability was then 
determined by MTT assay. Results were expressed as percentage of absorbance with 
respect to control (100%). Results are mean 土 S.D. of 3 determinations. Difference 
between extract treated and control was determined by Student's unpaired t-test. *p < 
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Fig. 3.6 Effect of partition extract (A) Ethyl-acetate; (B) Butanol on the proliferation 
of MCF-7 and MDA-MB-231 cells. Cells in a density of 5 x 10^ / ml were seeded in 
96-well plate and incubated at 37 5 % CO2 overnight. The cells were then treated 
with various concentrations of partition fractions for 48 hours. Cell viability was then 
determined by MTT assay. Results were expressed as percentage of absorbance with 
respect to control (100%). Results are mean 土 S.D. of 3 determinations. Difference 
between extract treated and control was determined by Student's unpaired t-test. *p < 







































































3.6 Anti-proliferative effect of various sub-fractions on breast cancer cells 
The effect of the sub-fractions generated from column chromatography towards the 
growth of the breast cancer cell lines were tested with MTT assay. The 
anti-proliferative effect of various fractions ranged from 25 |Lig/ml to 150 |Lig/ml was 
tested. Hs68 normal human cell line was used as a reference to study the effect of the 
sub-fractions on normal human cells. 
MTT results for fraction Fa were shown in Fig. 3.8. Up till a concentration of 150 
|ig/ml, no significant inhibition on the MCF-7 or MDA-MB-231 cells could be 
observed. 
The results of MTT assay for fraction Fb were shown in Fig. 3.9. A concentration 
dependent anti-proliferative effect could be observed. Fb inhibited the growth of 
MCF-7 cells significantly starting from a concentration of 50 |ag/ml while it only 
significantly reduced the growth of MDA-MB-231 cells above 100 ^ig/ml. 
The results of MTT assay of fraction Fc were shown in Fig. 3.10. Fc exhibited a 
dose-dependent anti-proliferative effect on both MCF-7 and MDA-MB-231 cells. 
Statistically significant inhibitory effect on the growth of MCF-7 cells was 
demonstrated at a concentration as low as 25 \ig/m\ while it only exhibited significant 
suppressive effect on MDA-MB-231 cells starting from a concentration of 50 jag/ml. 
Fc also inhibited the growth of Hs68 cells, but significant inhibitory effect was only 
observed at 150 |ig/ml which was the highest concentration tested. 
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Results of MTT assay of fraction Fd were shown in Fig. 3.11. Dose-dependent 
inhibitory effect on the growth of both MCF-7 and MDA-MB-231 cells could be seen. 
For MCF-7 cells, this suppressive effect was statistically significant starting from 50 
)jg/ml while a significant inhibition could already be seen at 25 |j,g/ml for 
MDA-MB-231 cells. However, Fd also suppressed the growth of Hs68 cells and the 
inhibition was considered as significant at 100 )ig/ml. 
Results of MTT test of fraction Fe were shown in Fig. 3.12. Significant growth 
suppressive effect on both breast cancer cell lines was observed at concentrations 
above 25 jig/ml. On the other hand, Fe also exhibited significant inhibitory effect on 
the proliferation of Hs68 cells at concentrations above 50 |ig/ml. 
Results of MTT test of fraction Ff and Fg were shown in Fig. 3.13. and Fig. 3.14 
respectively. Both of them elicited significant inhibitory effect on the growth of 
MCF-7 and MDA-MB-231 cells starting from a concentration of 25 jig/ml. On the 
other hand, statistically significant suppressive effect on the proliferation of Hs68 
cells could only be seen at concentration of 150 jig/ml which was the highest 
concentration tested. 
MTT results of Fh and Fi were shown in Fig. 3.15 and Fig. 3.16 respectively. Fh 
exhibited dose-dependent inhibitory effect on both breast cancer cell lines with 
statistical significance starting from 25 |ag/ml. For Fi, significant suppressive effect on 
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the growth of both breast cancer cell lines could be seen at concentrations above 50 
|ig/ml. 
IC50 of the various sub-fractions were summarized in Table 3.4. 
Table 3.4 Summary of IC50 of various sub-fractions (include SD) 
Fraction Human breast cancer cell line 
MCF-7 MDA-MB-231 
^ IC50 ^ 
(|Lig/ml) viability (|ag/ml) viability 
(%) at IC50 (0/0) at IC50 
Fb 54 ± 6.5 50 84 ±7 .6 50 
Fc 42 ±7 .0 50 65 ±1 .0 50 
Fd 67 ± 8.5 50 33 ±1 .3 50 
Fe 27 土 9.1 50 48 土 1.5 50 
Ff 36 ±6 .1 60 70 土 9.0 55 
Fg 28 土 8.7 50 45 ±8 .8 50 
Fh 45 ±7 .0 60 60 ±8.1 65 
The human breast cancer cells were treated with different sub-fractions of 
Acanthopanax for 48 hours at 37 ""C, 5 % CO2. The IC50 was then determined by MTT 
assays by 3 independent experiments. (Mean 土 S.D., n = 3 ) 
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Fig. 3.8. Effect of sub-fraction Fa of Acanthopanax on the proliferation of MCF-7 and 
MDA-MB-231 cells. Cells in a density of 5 x 10^ / ml were seeded in 96-well plate 
and incubated at 37 5 % CO2 overnight. The cells were then treated with various 
concentrations of Fa for 48 hours. Cell viability was then determined by MTT assay. 
Results were expressed as percentage of absorbance with respect to control (mean 士 
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Fig. 3.9. Effect of sub-fraction Fb of Acanthopanax on the proliferation of MCF-7 and 
MDA-MB-231 cells. Cells in a density of 5 x 10' / ml were seeded in 96-well plate 
and incubated at 37 ""C, 5 % CO2 overnight. The cells were then treated with various 
concentrations of Fb for 48 hours. Cell viability was then determined by MTT. 
Results were expressed as percentage of absorbance with respect to control (100%). 
Results are mean 士 S.D. of 3 determinations. Statistical significance between extract 
treated and control was determined by Student's unpaired t-lest. *p < 0.05 for MCF-7 
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Fig. 3.10 Effect of sub-fraction Fc of Acanthopanax on the proliferation of MCF-7, 
MDA-MB-231 and Hs68 cells. Cells in a density of 5 x 10^ / ml (MCF-7 and 
MDA-MB-231) or 7 x 10^ / ml (Hs68) were seeded in 96-well plate and incubated at 
37 5 % CO2 overnight. The cells were then treated with various concentrations of 
Fc for 48 hours. Cell viability was then determined by MTT assay. Results were 
expressed as percentage of absorbance with respect to control (100%). Results are 
mean 士 S.D. of 3-5 determinations. Statistical significance between extract treated and 
control was determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 
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Fig. 3.11 Effect of sub-fraction Fd of Acanthopanax on the proliferation of MCF-7, 
MDA-MB-231 and Hs68 cells. Cells in a density of 5 x 10' / ml (MCF-7 and 
MDA-MB-231) or 7 x 10^ / ml (Hs68) were seeded in 96-well plate and incubated at 
37 5 % CO2 overnight. The cells were then treated with various concentrations of 
Fd for 48 hours. Cell viability was then determined by MTT assy. Results were 
expressed as percentage of absorbance with respect to control (100%). Results are 
mean 土 S.D. of 3-5 determinations. Statistical significance between extract treated and 
control was determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 
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Fig. 3.12 Effect of sub-fraction Fe of Acanthopanax on the proliferation of MCF-7, 
MDA-MB-231 and Hs68 cells. Cells in a density of 5 x 10' / ml (MCF-7 and 
MDA-MB-231) or 7 x 10^ / ml (Hs68) were seeded in 96-well plate and incubated at 
37 5 o/o CO2 overnight. The cells were then treated with various concentrations of 
Fe for 48 hours. Cell viability was then determined by MTT assay. Results were 
expressed as percentage of absorbance with respect to control (100%). Results are 
mean ± S.D. of 3-5 determinations. Statistical significance between extract treated and 
control was determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 
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Fig. 3.13 Effect of sub-fraction Ff of Acanthopanax on the proliferation of MCF-7, 
MDA-MB-231, Hs68 cells. Cells in a density of 5 x 10' / ml (MCF-7 and 
MDA-MB-231) or 7 x 10^ / ml (Hs68) were seeded in 96-well plate and incubated at 
37 5 % CO2 overnight. The cells were then treated with various concentrations of 
Ff for 48 hours. Cell viability was then determined by MTT assay. Results were 
expressed as percentage of absorbance with respect to control (100%). Results are 
mean 士 S.D. of 3-5 determinations. Statistical significance between extract treated and 
control was determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 
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Fig. 3.14 Effect of sub-fraction Fg of Acanthopanax on the proliferation of MCF-7, 
MDA-MB-231 and Hs68 cells. Cells in a density of 5 x 10' / ml (MCF-7 and 
MDA-MB-231) or 7 x 10^ / ml (Hs68) were seeded in 96-well plate and incubated at 
37 5 o/o CO2 overnight. The cells were then treated with various concentrations of 
Fg for 48 hours. Cell viability was then determined by MTT assay. Results were 
expressed as percentage of absorbance with respect to control (100%). Results are 
mean 士 S.D. of 3-5 determinations. Statistical significance between extract treated and 
control was determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 
0.05 for MDA-MD-231 cells. 
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Fig .3.15 Effect of sub-fraction Fh of Acanthopanax on the proliferation of MCF-7 
and MDA-MB-231 cells. Cells were seeded in 96-well plate and incubated at 37 5 
% CO2 overnight. The cells were then treated with various concentrations of Fh for 48 
hours. Cell viability was then determined by MTT assay. Results were expressed as 
percentage of absorbance with respect to control (100%). Results are mean 土 S.D. of 3 
determinations. Statistical significance between extract treated and control was 
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Fig. 3.16. Effect of sub-fraction Fi of Acanthopanax on the proliferation of MCF-7 
and MDA-MB-231 cells. Cells were seeded in 96-well plate and incubated at 37 5 
% CO2 overnight. The cells were then treated with various concentrations of Fi for 48 
hours. Cell viability was then determined by MTT assay. Results were expressed as 
percentage of absorbance with respect to control (100%). Results are mean 土 S.D. of 3 
determinations. Statistical significance between extract treated and control was 
determined by Student's unpaired t-test. *p < 0.05 for MCF-7 cells, #p < 0.05 for 
MDA-MD-231 cells. 
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3.7 Effect of sub-fractions on PBMC proliferation 
PBMC isolated from buffy coat were treated with fractions Fc, Fd, Ff and Fg for 48 
hours and results of XTT assay were shown in Fig. 3.17. Among the tested 
sub-fractions, Fc exhibited the least effect on the growth of PBMC. 
3.8 Kinetic study of anti-proliferative effect of Fc 
MCF-7 and MDA-MB-231 cells were treated with Fc for 24 and 48 hours to study the 
effect of Fc on the proliferation of breast cancer cells at different time points. The 
MTT results were shown in Fig. 3.18. Fc demonstrated time-dependent effect on 
MCF-7 and MDA-MB-231 cells. Statistical significance could be found at 50 ^ig/ml 
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Fc Fd Ff Fg 
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25 > 0.05 > 0.05 > 0.05 > 0.05 
P value 50 >0.05 > 0.05 > 0.05 > 0.05 
100 >0.05 >0.05 > 0.05 > 0.05 
150 >0.05 <0.01 <0.01 <0.01 
Fig. 3.17 Effect of sub-fractions on the proliferation of PBMC. Cells were seeded in 
96-well plate and incubated at 37 5 % CO2 overnight. The cells were then treated 
with various concentrations of sub-fractions for 48 hours. Cell viability was then 
determined by XTT assay. Results were expressed as percentage of absorbance with 
respect to control (100%). Results are mean 士 S.D. of 3 determinations. Statistical 
significance between extract treated and control was determined by Student's 
unpaired t-test and the results were listed on the table above. 
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Fig. 3.18. Effect of sub-fraction Fc of Acanthopanax on the proliferation of MCF-7 
and MDA-MB-231 cells after 24 and 48 hours of treatment. Cells were seeded in 
96-well plate and incubated at 37 5 % CO2 overnight. The cells were then treated 
with various concentrations of Fc for 24 or 48 hours. Cell viability was then 
determined by MTT assay. Results were expressed as percentage of absorbance with 
respect to control (100%). Results are mean 土 S.D. of 3 determinations. Statistical 
significance between 24 and 48 hour treatment was determined by Student's unpaired 
t-test. *p < 0.05 
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3.9. Flow cytometric analysis 
The underlying mechanisms of the anti-proliferative effect of sub-fraction Fc towards 
the breast cancer cell lines were further investigated by using of flow cytometry. 
Aspects including mitochondrial membrane potential change, cell cycle change and 
extemalization of PS molecules were studied. 
3.9.1 JC-1 staining 
Various concentrations of Fc were used to treat MCF-7 and MDA-MB-231 cells for 
48 hours and the changes in mitochondrial membrane potential were studied by 
staining the cells with JC-1 and analyzed with flow cytometry. The data were then 
interpreted with software WinMDI 2.9. Results of JC-1 staining towards MCF-7 and 
MDA-MB-231 cells were shown in Fig. 3.19 and Fig. 3.20 respectively. The results 
revealed that 48-hour treatment of Fc would induce mitochondrial membrane 
depolarization in both MCF-7 and MDA-MB-231 cells when compared with the 
control. The increase in percentage of cells with depolarized mitochondrial membrane 
was found to be dose-dependent. 
3.9.2 Annexin-PI labeling 
MCF-7 and MDA-MB-231 cells were treated with Fc for 48 hours and then labeled 
with FITC-conjugated Annexin V and PI. Results were presented as bivariant dot plot 
in Fig. 3.21 and Fig. 3.22 for MCF-7 and MDA-MB-231 cells respectively. Treatment 
of Fc could induce a shift in cell population from AV, PI double negative area to AV 
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positive, PI negative and AV, PI double positive area sequentially in MDA-MB-231 
cells. Although Fc could also create numerical increase in apoptotic region in MCF-7 
cells, the pattern is somehow different from that observed in MDA-MB-231 cells. No 
discrete population could be seen in AV positive and PI negative area and there seems 
no track of movement from AV positive and PI negative area to AV, PI double positive 
area. 
3.9.3 Cell cycle analysis 
DNA was extracted from breast cancer cells treated with Fc for 48 hours and then 
subjected to cell cycle analysis. Data were presented as histograms in Fig. 3.23 and 
Fig. 3.24 for MCF-7 and MDA-MB-231 cells respectively. For MCF-7 cells, no 
obvious sub-Gl peak could be observed, even if 80 |ag/ml of Fc were added. In 
contrast, a dose-dependent increase in percentage of cells under G1 phase could be 
observed upon the treatment of Fc. At the same time, percentage of cells in S or G2/M 
phase decreased accordingly after the treatment with Fc. On the other hand, treatment 
of MDA-MB-231 cells with Fc resulted in an increase in sub-Gl peak and a 
dose-dependent effect could be seen. Numerical data were shown in Table 3.5. 
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3»10 DNA fragmentation assay 
After 48 hours of treatment with Fc, genomic DNA was extracted from MCF-7 and 
MDA-MB-231 cells and analyzed with gel electrophoresis. Results of DNA 
fragmentation assay of MCF-7 and MDA-MB-231 cells were shown in Fig. 3.25 and 
Fig. 3.26 respectively. No DNA ladder could be observed in Fc treated MCF-7 cells 
although the highest concentration added was as high as 80 }ig/ml. In contrast, 
intemucleosomal DNA fragments could be seen in Fc treated MDA-MB-231 cells. 
And a dose-dependent effect was obvious at high concentrations (70 and 80 }ig/ml). 
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Fig. 3.25 DNA fragmentation analysis of MDA-MB-231 cells after 48 hours of 
treatment with various concentrations of sub-fraction Fc of Acanthopanax. Genomic 
DNA was prepared as described in Materials and Methods and analyzed with 1.5 % 
agarose gel electrophoresis. The figure presented is representative of the results of 
three individual experiments. 
Lane 1 - vehicle control; Lane 2 - 5: Fc of concentrations 50, 60, 70 and 80 \ig/m\ 
respectively; Lane 6 — Marker 
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Fig. 3.26 DNA fragmentation analysis of MCF-7 cells after 48 hours of treatment with 
various concentrations of sub-fraction Fc of Acanthopanax. Genomic DNA was 
prepared as described in Materials and Methods and analyzed with 1.5 % agarose gel 
electrophoresis. The figure presented is representative of the results of three 
individual experiments. 
Lane 1 - Marker ； Lane 2 - Vehicle control; Lane 3 - : Fc of concentrations 50，60, 70 
and 80 |ag/ml respectively. 
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3.11 Western blotting 
According to the results of flow cytometry analysis and DNA fragmentation assay, the 
amounts of various proteins in MCF-7 and MDA-MB-231 cells were studied with the 
help of Western blotting. 
Since the results mentioned above suggested that Fc may induce apoptosis in 
MDA-MB-231 cells, some apoptotic regulators were probed with specific antibodies 
and the results were shown in Fig. 3.27 to 3.30. The expression of anti-apoptotic 
protein Bcl-2 was decreased upon the treatment with Fc for 48 hours. As shown in Fig. 
3.27, the amount of Bcl-2 decreased as the concentration of Fc added was increased. 
Besides, the treatment of MDA-MB-231 cells with Fc could induce the cleavage of 
procaspase-9 into caspase-9 since the amount of procapase-9 decreased upon Fc 
treatment while the amount of caspase-9 increased accordingly (Fig. 3.28). And a 
dose-dependent manner could be observed, the higher the concentration used, the 
more the cleavage of procaspase-9. Accompanying this was the decrease in 
procaspase-3 in Fc treated MDA-MB-231 cells. A concentration dependent effect 
could be observed in the decrement of procaspase-3 (Fig. 3.29). In addition, the 
amount of PARP found was also lowered after the exposure to Fc. The band of PARP 
detected was reduced in a dose-dependent manner. 
On the other hand, previous results suggested the possibility of GO/Gl cell cycle 
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arrest maybe induced by Fc. As a result, proteins which play important roles in 
regulating cell cycle were probed in MCF-7 cells and the results were shown in Fig. 
3.31 and Fig. 3.32. Both cyclin Di and cdk 2 were required for the progression from 
phase G1 phase to S phase. Upon the addition of Fc, the amounts of both cyclin Di 
and cdk 2 were found to be decreased in a dose-dependent manner. This suggested 
that Fc could induce GO/Gl cell cycle arrest in MCF-7 cells via modulation of cyclin 
Di and cdk 2 protein expression. 
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Bcl-2 
Vehicle 50 |ag/ml 60 |Lig/ml 80 \ig/m\ 
Control Fc Fc Fc 
� ‘ : 考 ， ‘ ,28kDa 
Fig. 3.27 Effect of sub-fraction Fc of Acanthopanax on the expression of Bcl-2 
protein in MDA-MB-231 cells. 2x10^ MDA-MB-231 cells were seeded in 100 mm^ 
dish overnight. The cells were then treated with various concentrations of Fc and 
incubated for another 48 hours. Both floating and adherent cells were collected for 
analysis. Cell lysates were prepared and normalized for total protein content. 
Normalized lysates were analyzed by SDS-PAGE and immunoblotting using 
anti-Bcl-2 antibodies. Vehicle control was prepared by treating cells with 0.5% 
DMSO, which is equivalent to the DMSO content in Fc treatment groups. |3-actin was 
used for internal normalization. Results presented are representative of 3 individual 
experiments. 
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Procaspase-9 and caspase-9 
Vehicle 50 ^ig/ml 60|Lig/ml SO^ig/ml 
Control Fc Fc Fc 
: ‘ : 多 ： ： ― 
37 kDa fragment 
: 3 5 kDa fragment 
42 kDa 
Fig. 3.28 Effect of sub-fraction Fc of Acanthopanax on the expression of procaspase-9 
and caspase-9 in MDA-MB-231 cells. 2x10^ MDA-MB-231 cells were seeded in 100 
mm^ dish overnight. The cells were then treated with various concentrations of Fc and 
incubated for another 48 hours. Both floating and adherent cells were collected for 
analysis. Cell lysates were prepared and normalized for total protein content. 
Normalized lysates were analyzed by SDS-PAGE and immunoblotting using 
anti-procaspase-9 and anti-caspase-9 antibodies. Vehicle control was prepared by 
treating cells with 0.5% DMSO, which is equivalent to the DMSO content in Fc 
treatment groups. P-actin was used for internal normalization. Results presented are 
representative of 3 individual experiments. 
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Procaspase-3 
Vehicle 50 |ag/ml 60 |ig/ml 80 |ig/ml 
Control Fc Fc Fc 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ procaspase-3 
P - t i n 
Fig. 3.29 Effect of sub-fraction Fc of Acanthopanax on the expression of procaspase-3 
in MDA-MB-231 cells. 2x10^ MDA-MB-231 cells were seeded in 100 mm^ dish 
overnight. The cells were then treated with various concentrations of Fc and incubated 
for another 48 hours. Both floating and adherent cells were collected for analysis. Cell 
lysates were prepared and normalized for total protein content. Normalized lysates 
were analyzed by SDS-PAGE and immunoblotting using anti-procaspase-3 antibodies. 
Vehicle control was prepared by treating cells with 0.5% DMSO, which is equivalent 
to the DMSO content in Fc treatment groups. P-actin was used for internal 
normalization. Results presented are representative of 3 individual experiments. 
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PARP 
Vehicle 50 jig/ml 60 |Lig/ml 80 jag/ml 
Control Fc Fc Fc 
PARP 
‘ “ ' � v e , ' ； .： ‘‘ 116 kDa 
^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ ^ P-actin 
42 kDa 
Fig. 3.30 Effect of sub-fraction Fc of Acanthopanax on the expression of PARP in 
MDA-MB-231 cells. 2x10^ MDA-MB-231 cells were seeded in 100 mm^ dish 
overnight. The cells were then treated with various concentrations of Fc and incubated 
for another 48 hours. Both floating and adherent cells were collected for analysis. Cell 
lysates were prepared and normalized for total protein content. Normalized lysates 
were analyzed by SDS-PAGE and immunoblotting using anti-PARP antibodies. 
Vehicle control was prepared by treating cells with 0.5% DMSO, which is equivalent 
to the DMSO content in Fc treatment groups. P-actin was used for internal 
normalization. Results presented are representative of 3 individual experiments. 
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Cyclin D, 
Vehicle 40 |ag/ml 50 |Lig/ml 80 )ig/ml 
Control Fc Fc Fc 
Cyclin Di 
33 kDa 
Fig. 3.31 Effect of sub-fraction Fc of Acanthopanax on the expression of cyclin D! in 
MCF-7 cells. 2x10^ MCF-7 cells were seeded in 100 mm^ dish overnight. The cells 
were then treated with various concentrations of Fc and incubated for another 48 
hours. Both floating and adherent cells were collected for analysis. Cell lysates were 
prepared and normalized for total protein content. Normalized lysates were analyzed 
by SDS-PAGE and immunoblotting using anti-cyclin D] antibodies. Vehicle control 
was prepared by treating cells with 0.5% DMSO, which is equivalent to the DMSO 
content in Fc treatment groups. (3-actin was used for internal normalization. Results 
presented are representative of 3 individual experiments. 
97 
Cdk 2 
Vehicle 40 ^ig/ml 50 |ig/ml 80 昭/ml 
Control Fc Fc Fc 
33 kDa 
" “ ‘ ‘ ' � “ , ‘ ‘ ‘ ‘ ‘ ‘ ‘ 42 kDa 
Fig. 3.32 Effect of sub-fraction Fc of Acanthopanax on the expression of cdk 2 in 
MCF-7 cells. 2x10^ MCF-7 cells were seeded in 100 mm^ dish overnight. The cells 
were then treated with various concentrations of Fc and incubated for another 48 
hours. Both floating and adherent cells were collected for analysis. Cell lysates were 
prepared and normalized for total protein content. Normalized lysates were analyzed 
by SDS-PAGE and immunoblotting using anti-cdk 2 antibodies. Vehicle control was 
prepared by treating cells with 0.5% DMSO, which is equivalent to the DMSO 
content in Fc treatment groups, p-actin was used for internal normalization. Results 
presented are representative of 3 individual experiments. 
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Chapter 4 Discussion 
Astragalus and Maitake have been long known to be effective in treating tumor. 
There are lots of studies about the effects of Astragalus and Maitake towards our 
immune system and how these effects could benefit our body defense against the 
invasion of cancer cells. It has been proposed that the anti-tumor effect of Astragalus 
and Maitake was mediated through boosting the host immunity. However, there are 
only limited reports about the cytotoxic action of Astragalus and Maitake towards 
cancer cells. Although there are investigations reporting that apoptosis induction may 
play a part in the anti-tumor effect of Astragalus or Maitake, the cytotoxic effect of 
Astragalus or Maitake has not been fully investigated, therefore this raised our interest 
about the study of the cytotoxic effect of Astragalus and Maitake. 
On the other hand, the anti-tumor effect of Acanthopanax is less 
well-characterized. Previously, there are reports about the cytotoxic effect of 
Acanthopanax extracts towards cancer cells such as stomach cancer KATO III cells or 
other leukemia cell lines as described above. There were no reports about the 
anti-tumor activities of Acanthopanax towards breast cancer or hepatoma. Moreover, 
the detailed mechanism behind the anti-tumor activity of Acanthopanax was not clear 
at the moment. Therefore, we would like to study the direct cytotoxic effect of these 
three herbs towards cancer cells. One human hepatoma cell line, Hep G2 and two 
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human breast cancer cell lines, MCF-7 and MDA-MB-231 were employed in this 
investigation. The two breast cancer cell lines used represent different stages of breast 
cancer. Estrogen receptor positive MCF-7 cells are regarded as prototype of early 
stage of breast cancer which is hormone-sensitive while estrogen receptor negative 
MDA-MB-231 cells reflect a latter stage of breast cancer which is more invasive and 
not hormone-sensitive. 
The results of MTT assay was employed as the screening test for checking the 
anti-proliferative effect of the extracts towards different cancer cell lines since it is 
well-established that MTT could correlate the number of living cells with the 
formazan salt formed (Alley et al., 1988;Mosmann, 1983). Therefore, it is a rapid, 
easy and valid assay in studying the anti-proliferative effect of various herbal extracts. 
Previously, different classes of compounds, including polysaccharides, 
flavanoids, saponins, sterols, courmarins and amino acids, were isolated from 
Astragalus, Maitake and Acanthopanax (Zhang et al, 2002 ； Wang et al, 2007; Wang et 
al, 2002). These compunds vary in polarity due to their differences in chemical 
structure. Gernerally speaking, compounds with higher polarities, like 
polysaccharides, flavonids or amino acids, are more likely to be found in the aqueous 
or 50 o/o ethanolic extract. On the other hand, compounds like saponins, sterols or 
courmarins are less polar, and therefore maybe found mainly in 50 % or 95 % 
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ethanolic extracts. 
The results of MTT assays of aqueous extracts of Astragalus and Maitake 
revealed that both extracts did not have much impact on the proliferation on the three 
tested cancer cell lines since none of the extracts exhibited significant effect on the 
growth of the cancer cells. Therefore, we tried to draw out the constituents with lower 
polarity by extracting the herbs with 50 % and 95 % ethanol. However, no significant 
inhibitory effect on cell viabilities in the tested cells was seen even if we changed the 
extraction solvent. Therefore, we concluded that aqueous, 50 % and 95 % ethanol 
extracts of Astragalus and Maitake did not possess cytotoxic effect towards the three 
tested cell lines, below concentration of 800 |ag/mL 
In contrast, the aqueous extract of Acanthopanax exhibited suppressive effect on 
MCF-7, MDA-MB-231 and Hep G2 cells in a dose-dependent manner. The aqueous 
extact of Acanthopanax reduced the proliferation of MCF-7, MDA-MB-231 and Hep 
G2 cells to 50 % at concentrations about 355 |Lig/ml, 355 jig/ml and 400 \xg/m\ 
respectively. The anti-proliferative effect of Acanthopanax extract towards breast 
cancer cells was relatively stronger. In fact, statistically significant difference could be 
found between the anti-proliferative effect on breast cancer cells and Hep G2 cells, in 
concentrations from 300 |ig/ml to 800 ^g /ml This suggested that breast cancer cells 
were more sensitive to the suppressive effect of Acanthopanax when compared with 
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Hep G2 cells. In regard of this, we have decided to concentrate our effort in studying 
the anti-proliferative effect of Acanthopanax extract on breast cancer cells. In addition, 
the anti-proliferative effect of Acanthopanax extract on Hs68 cell line which is an 
untransformed human fibroblast cell line was also tested and the 50 % inhibition of 
proliferation of Hs68 cells was seen at a concentration of 720 \ig/m\, which was much 
higher than that on cancer cells. Acanthopanax aqueous extract suppressed 
proliferation of breast cancer cells at a higher extent when compared with normal 
cells. The differential effect of Acanthopanax on breast cancer cells and normal cells 
suggests that the anti-proliferative effect of Acanthopanax extract may possess 
selectivity to certain extent. 
Acanthopanax was extracted and fractionated previously by other groups. Hot 
methanol extract of Acanthopanax was fractionated by partitioning in a sequence with 
ether, chloroform and then butan-l-ol (Deyama et al” 2001). Therefore, similar 
protocol was adopted except that we added another organic solvent ethyl-acetate to 
the fractionation protocol, just like many other herbs that were fractionated before 
(Chiu et al., 2006). The addition of ethyl-acetate into the fractionation protocol could 
further sub-localize the compounds and achieving a more detailed fractionation. The 
results in other investigations showed that sometimes the ethyl-acetate fraction 
exhibited promising anti-tumor activities, and the ethyl-acetate may play a vital role 
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in the whole fractionation protocol (Chiu et al, 2006). Another modification we made 
to the fractionation protocol is that we replaced the petroleum ether as suggested in 
other studies with hexane (Wu et al., 2008). The replacement is due to the fact that 
petroleum ether is a mixture of volatile hydrocarbon rather than a single compound 
which is mainly composed of alkanes such as pentane, hexane and heptane. 
Considering the fact that petroleum ether and hexane share similar polarity, replacing 
petroleum ether with hexane would make the fractionation protocol more 
reproducible. 
Among the four partition fractions, chloroform and ethyl-acetate demonstrated 
the strongest anti-proliferative effect on the breast cancer cell lines. Chloroform 
fraction reduced the proliferation of MCF-7 and MDA-MB-231 cells to half at 50 
|Lig/ml and 80 |ag/ml respectively while ethyl-acetate fraction reduced the proliferation 
of both breast cancer cell lines to half at 70 |Lig/ml. Other fractions, such as hexane 
fraction containing less polar compounds and butanol fraction consisting of 
compounds with higher polarity, inhibited the proliferation of cancer cells less 
effectively. Therefore, we may say that compounds responsible for the anti-tumor 
activity of Acanthopanax should have a polarity similar to that of chloroform and 
ethyl-acetate. Considering the fact that the yield of ethyl-acetate fraction (9.78%) was 
much higher than that of chloroform fraction (2.62%), constituents in ethyl-acetate 
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fraction may play a more important role in the anti-tumor effect of Acanthopanax. 
Therefore, the ethyl-acetate fraction rather than chloroform fraction was chosen for 
further investigation. 
Constituents in ethyl-acetate fraction were further isolated by employing silica 
gel as the stationary phase of column chromatography. Discontinuous gradient elution 
was performed. Mobile phase of hexane and ethyl-acetate in a ratio of 5 : 3 was used 
at the start and then replaced by a more polar solvent system consisting of 10 : 9 
hexane and ethyl-acetate, and then eluted with pure ethyl-acetate and methanol. The 
yield of the various sub-fractions was listed in Table 3.4. Fi was the sub-fraction with 
the highest yield, which was more than 50 %, followed by Fg and Fc. MTT assay was 
used to investigate the anti-proliferative effect of the sub-fractions. And the results of 
Fi revealed that Fi did not have much effect on breast cancer cell proliferation with an 
IC50 of higher than 150 jig/ml. Since Fi is the last fraction eluted from the column, Fi 
contains compounds with relatively higher polarity. As indicated in the comparison of 
the anti-tumor activities of partition fractions, polar compounds in Acanthopanax 
extract exhibited weaker anti-tumor activity relative to their counterpart with lower 
polarity. Therefore, the weak anti-tumor activity of Fi found is actually consistent 
with the results of anti-proliferative effect of the partition fractions. 
The anti-proliferative effect on MCF-7 and MDA-MB-231 cells were 
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investigated for every fraction. The MTT results of the sub-fractions were shown in 
Fig. 3.8- Fig. 3.16. One point worth noting is that the IC50 of the sub-fractions on 
MCF-7 cells are lower than their IC50 on MDA-MB-231 cells in most cases when we 
compared the anti-proliferative effect of the same fraction on the two breast cancer 
cell lines. It seems that MCF-7 cells are more susceptible to the growth-inhibitory 
effect of Acanthopanax extract. 
All the sub-fractions exhibited anti-proliferative effect on the growth of breast 
cancer cells, although they varied in potency. In general, all the sub-fractions would 
inhibit the growth of both breast cancer cell lines significantly at a concentration of 50 
[ig/ml except for Fa and Fb. Among the sub-fractions, Fg demonstrated the strongest 
anti-proliferative effect on MCF-7 and MDA-MB-231 cells. Surprisingly, when we 
compared the anti-proliferative effect of ethyl-acetate fraction with those of 
sub-fractions generated from column chromatography, the difference between them is 
not obvious. This may be explained by the fact that most of the sub-fractions possess 
certain degree of anti-tumor activities. This means that there are multiple compounds 
contributing to the overall anti-tumor activities of Acanthopanax rather than one 
single compound with outstanding anti-tumor activity. This accounts for the majority 
of anti-tumor effect of the herb. Although the largest sub-fraction Fi did not exhibit 
strong anti-tumor activities, the interactions of other sub-fractions could be 
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complicated and the possibility of synergistic effect with each other should not be 
excluded and thereby contributing to the comparatively strong anti-tumor effect of 
ethyl-acetate fraction. 
Other than potency, the selectivity of the anti-tumor drug is also of a great 
concern. Obviously, it will have little practical use if a drug could not differentiate 
between normal cells and malignant cells. In order to see whether the extract 
exhibited differential effect on the growth of malignant cells and normal cells, the 
effects of the sub-fractions Fc, Fd, Fe, Fg and Ff on the proliferation of normal human 
fibroblast cells Hs68 were also investigated and the results were compared with the 
anti-proliferative effect on the two breast cancer cell lines to see if there is any 
statistical significance. 
Fc reduced proliferation of Hs68 cells to 50 % at 138 |ag/ml and statistical 
significance (p < 0.01) could be found between the effects of Fc on the two breast 
cancer cell lines and Hs68 cells from concentration of 50 jag/ml to 100 |ig/ml. 
Although the proliferation of Hs68 cells was reduced to about 30 % of control, Fc 
could already suppress the growth of MCF-7 and MDA-MB-231 cells to 10 % of 
control at 100 [ig/m\ while the proliferation of Hs68 cells stayed about the same as 
control at such a concentration. Therefore, we can say that Fc exhibited selective 
anti-proliferative effect on breast cancer cells, at least at concentrations below 100 
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)ag/ml. For Fd, statistically significant difference in anti-proliferative effect between 
breast cancer cells and Hs68 cells could only be seen at concentrations from 25 to 50 
|Ag/ml. On the other hand, both Ff and Fg also demonstrated selective 
anti-proliferative effect on breast cancer cells. Ff showed significant difference in 
inhibiting MDA-MB-231 and Hs68 cells in concentrations from 25 [ig/m\ to 150 
)ig/ml while significant difference could be seen between MCF-7 and Hs68 cells at all 
tested concentrations. Similarly, significant difference between the suppressive effect 
of Fg on the growth of breast cancer cells and Hs68 cells could be found at all tested 
concentrations. In contrast, sub-fraction Fe did not exhibit selective anti-proliferative 
effect on breast cancer cells. There was no significant difference between the 
anti-proliferative actions on breast cancer cells and Hs68 cells at all tested 
concentrations, if we compare their MTT results. In short, sub-fractions Fc, Fd, Ff and 
Fg had shown selectivity in inhibiting human breast cancer cells growth over normal 
fibroblast cells Hs68 cells. 
Yet, to further confirm that the sub-fractions possess selectivity in inhibiting 
human breast cancer cells growth over normal cells, we have used another type of 
normal human cells (PBMC). Previously, other groups have also employed PBMC in 
comparing the cytotoxicity of anti-tumor compounds on tumor cells and normal cells 
(Lopez-Gonzalez et al., 2004;Sun et al., 2005;Yan et al., 2008;Sreenivasan et al., 
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2006b). PBMC from buffy coats of healthy donors could be isolated by differential 
centrifugation using Ficoll- Paque ™ Plus solution and therefore PBMC are a rapid 
and convenient source of normal human cells. The major cell populations found in 
PBMC include B cells, T cells, natural killer cells and monocytes which are the 
immune cells circulating in our cardiovascular system. The proliferation of PBMC 
also reflects how our immunity responds to the drug treatment. Mitogenic effect on 
PBMC is considered as a sign of activation of immune cells while suppressive effect 
on PBMC proliferation is regarded as immunosuppression. Therefore, studying the 
effect of herbal extract on PBMC proliferation could also give us a hint and insight on 
how the extract affects the immune system. Taken the fact that immunosuppression is 
one of the common side effects of cancer chemotherapy, testing the effect of 
anti-tumor drug on immune cells is reasonable and vital. 
We have investigated the proliferation of PBMC under the treatment of 
sub-fractions Fc, Fd, Ff and Fg, which have demonstrated to have specific anti-tumor 
effect when Hs68 cells were used as normal cell control. Since PBMC are suspension 
cells rather than adherent in nature, XTT assay was used to replace MTT assay for 
monitoring the proliferation of PBMC. XTT assay is similar to MTT assay in nature, 
both of them measure the colorimetric change accompanying the conversion of 
tetrazolium salt into fomazan salt by mitochondrial enzymes. Since the formazan salt 
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generated in XTT salt reduction is positively charged and therefore water-soluble, an 
aspiration step could be skipped for XTT assay. As PBMC are suspension in nature, it 
is possible that PBMC would be removed together with the medium during the 
aspiration step required in MTT assay. Therefore，replacement of MTT with XTT 
assay could reduce the experimental error due to cell removal and gave a more 
accurate result. 
The results of XTT assay were summarized in Fig. 3.17. Fd, Ff and Fg exhibited 
suppressive effect on the proliferation of PBMC with statistical significance at a 
concentration of 150 [ig/ml Fd and Fg reduced the proliferation of PBMC to more 
than 50 % at concentrations below 150 |Lig/mL Although Fg only reduced the PBMC 
proliferation for about 30 %, significant inhibitory effect could still be seen. In 
contrast, Fc did not have any statistically significant effect on the growth of PBMC at 
all concentrations tested. PBMC proliferation remained comparable to that of control 
at 150 jag/ml of Fc while more than 90 % inhibition was seen at such concentration on 
the growth of human breast cancer cells. This suggested that Fc demonstrated 
selective inhibitory effect on human breast cancer cells. 
From the MTT and XTT results, we can see that the anti-tumor activities of the 
various sub-fractions differed from each other in terms of potency and selectivity. 
Sub-fractions like Fe possessed potent anti-proliferative effect on both breast cancer 
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cell lines but it did not demonstrate much selectivity when we compared its effect 
with Hs68 cells and PBMC. Taking the potency of anti-proliferative effect, selectivity 
and percentage yield into consideration, Fc could be one the sub-fractions that gave 
the most promising anti-tumor activity. Therefore, the mechanism underlying the 
anti-proliferative effect of Fc was further investigated. Nevertheless, the anti-tumor 
activity of other sub-fractions, such as Fg and Ff are still possible targets for future 
investigations. 
The previous studies about the anti-tumor effect of Acanthopanax extract 
proposed that Acanthopanax extract was able to induce apoptosis in tumor cells, such 
as stomach cancer cell line KATO III (Hibasami et al., 2000b). With reference to this, 
we explored the possibility that Fc may also suppress the human breast cancer cells 
through activating the apoptotic pathway. 
To investigate whether Fc could induce apoptosis in breast carcinoma, Fc treated 
breast cancer cells were characterized with some common features or hallmarks of 
apoptosis through flow cytometric analysis owing to the its high efficiency of 
studying biochemical changes in a large number of cells within a short period of time. 
In many other studies, apoptosis is accompanied with the depolarization of 
mitochondrial membrane (Lu et al., 2008;Yao et al., 2008;Baxa et al., 2005). JC-1 
(5,5' ,6,6' - tetrachloro-1,1' ,3,3' - tetraethylbenzimidazolcarbocyanine iodide) is a 
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membrane-permeable lipophilic fluorochrome that is commonly used in evaluating 
the mitochondrial membrane potential (A\|;m). JC-1 exists in two forms, dependent on 
its concentration. It would exist as monomer under low concentration and green 
fluorescence would be emitted. On the other hand, aggregate (J-aggregates) formation 
will be favored at a high concentration and the formation of aggregate is accompanied 
by a red-spectral shift which could be measured in the red channel of flow cytometer. 
On the other hand, the dye concentration found in cells is dependent on the uptake of 
the dye into the mitochondria. JC-1 penetrates membrane of the living cells as 
monomers, and the uptake of JC-1 into the mitochondria is driven by the Aij/m. 
Polarized mitochondrial membrane of living cells favors the entry of JC-1 and 
therefore a high JC-1 concentration is reached in mitochondria of living cells, results 
in a red-spectral shift due to the formation of the J-aggregates. On the contrary, dead 
cells or apoptotic cells (intrinsic pathway), would have a depolarized mitochondrial 
membrane, results in less rapid accumulation of JC-1 inside the mitochondria. Since 
most of the dye remains as monomers, apoptotic or dead cells exhibited a higher 
emission of green fluorescence. 
From Fig. 3.19 and 3.20, the breast cancer cells population shifted to area with 
higher level of green fluorescence emission upon treatment with Fc, and a 
dose-dependent manner could be observed. This shows that Fc could induce 
111 
mitochondrial membrane depolarization in both MCF-7 and MDA-MB-231 cells. 
However, mitochondrial membrane depolarization is not a unique feature of apoptosis, 
similar event could also be seen in necrotic cells. Therefore，to confirm the activation 
of apoptotic pathway, phosphatidylserine extemalization was studied. 
Phosphatidylserine (PS) extemalization is one of the earliest morphological 
features that can be observed in apoptotic cells. The extemalization of PS, which 
normally confined to the inner leaflet of the cell membrane, serves to provide an 'eat 
me, signal to the scavengers like macrophages which rapidly recognize and engulf the 
apoptotic cells to prevent onset of inflammation process (Hengartner, 2001). 
The exposure of PS to the extracellular environment could be labeled by a 
protein known as Annexin-V. It is a vascular anti-coagulant protein in humans with 
high affinity towards the PS molecules. The use of Annexin-V conjugated to FITC 
allows cytometric detection of apoptosis by the fluorescence emission. 
Since necrotic cells would also expose PS due to the loss of membrane integrity, 
a co-staining with a vital dye propidium-iodide would be required for differentiating 
cells in early apoptosis from that in necrosis. Propidium-iodide is a DNA fluorescent 
intercalating agent which stains the DNA when the membrane integrity is lost. As 
cells in early apoptosis would express PS molecule to the extracellular environment 
meanwhile maintaining an intact cell membrane, they could be identified as cell 
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population of Annexin-V positive and PI negative and located in the lower right area. 
As shown in Fig. 3.22, the treatment of MDA-MB-231 cells with Fc resulted in 
the movement of cells from the area of viable cells in the lower left corner, to the area 
of cells in early apoptosis and late apoptosis. As we increased the dose of Fc, the 
percentage of cells found in apoptotic area was also increased, indicating the 
concentration dependency. More importantly, the tracks of cell movement from the 
viable area to the apoptotic area could be seen clearly. This result provides strong 
evidence that Fc cause apoptosis in MDA-MB-231 cells. 
On the other hand, though a dose-dependent increase in cells in the apoptotic 
area could also be seen in MCF-7 cells treated with Fc, the track of movement of cells 
was absent in the graph. It seems that the MCF-7 cells instantly transferred to the top 
right comer without by-passing the area considered as early apoptosis. In other words, 
the PS cannot not be detected when the cell integrity was still maintained. It is 
doubtful whether MCF-7 cells underwent apoptosis after the treatment of Fc. In 
contrast, the apoptotic effect of Fc on MDA-MB-231 cells is more promising 
comparatively. 
Flow cytometric analysis on the DNA content of the malignant cells treated with 
Fc was also performed to see if Fc had any effect on the cell cycle regulations of the 
breast cancer cells. Propidium-iodide is a tluorochrome that would bind 
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stoichiometrically to DNA molecules, and as a result reflect the DNA content of the 
cells. In this study, PI and flow cytometry were used to determine the cell cycle and 
apoptosis in the breast cancer cells. The DNA histograms of MDA-MB-231 cells after 
48 hours of treatment with Fc were shown in Fig. 3.24. It was reported that the 
apoptotic cells would undergo DNA fragmentation, and therefore its DNA content 
would be less than that of cells in G1 phase and generating a sub-Gl peak lying right 
before the GO/Gl peak (Zhang et al., 2006). In our results, sub-Gl peak could be seen 
representing the existence of apoptotic cells. More importantly, the sub-Gl peak 
content increased as we raise the dose of Fc added and a more than 10-fold elevation 
in sub-Gl peak compared with control was attained when 90 ^ig/ml Fc was used. This 
result further supports the argument that Fc could induce apoptosis in MDA-MB-231 
cells. The presence of sub-Gl peak in Fc-treated MDA-MB-231 cells was supported 
by the results of DNA fragmentation (Fig. 3.25). After 48 hours of treatment with Fc, 
genomic DNA in MDA-MB-231 cells was extracted and electrophoresis was 
performed. Intemucleosomal ladder pattern was found in Fc-treated MDA-MB-231 
cells and the DNA fragmentation became more and more obvious when the dose was 
increased. Upon treatment with Fc, a decrease in the percentage of cells could be seen 
in Gl , Sand G2/M phase of cell cycle, without accumulation of cells in a single phase. 
Therefore, we can say that Fc inhibited the MDA-MB-231 cell growth by inducing 
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apoptosis rather than arresting the cell cycle progression. 
The DNA histograms of MCF-7 cells that have been treated with Fc for 48 hours 
were shown in Fig. 3.24. In contrast to the results of MDA-MB-231 cells, no sub-Gl 
peak could be seen at all concentrations tested. This result was justified by the DNA 
fragmentation assay. After 48 hours of treatment with Fc, no DNA ladder was 
observed in gel electrophoresis at a concentration of 80 |ig/ml. However, changes in 
the proportion of the cells in various phases of cell cycle could be observed. Upon 
treatment with Fc, the cell population staying in the G1 phase increased in a 
dose-dependent manner. Seventeen % elevation of cells in G1 phase was reached at 
60 |dg/ml compared to that of control. Meanwhile, the percentage of cells that could 
be found in S phase and G2/M phase decreased. After the treatment with Fc, MCF-7 
cells could no longer progress from G1 phase to the later phase of cell cycle and 
therefore cell accumulation in G1 phase was found. Therefore, it is likely that the 
suppressive effect of Fc on the growth of MCF-7 cells was through the arrestment of 
cells in G1 phase and stopped any further proliferation. 
Since the previous results like PS extemalization, mitochondrial membrane 
depolarization and DNA fragmentation suggested that Fc may induce apoptosis in 
MDA-MB-231 cells, the apoptotic machinery activated was characterized through the 
use of Western blotting analysis. It was found that Fc could reduce the Bcl-2 
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expression dose-dependently in MDA-MB-231 cells after 48 hours of treatment (Fig. 
3.27). Bcl-2 is recognized as an anti-apoptotic member in Bcl-2 family, reduction of 
Bcl-2 would favor the activation of the apoptotic pathway. Accompanying the 
reduction in Bcl-2 expression, the amount of procaspase-9 was also found to be 
lowered in a dose-dependent manner after treatment with Fc. The decrease in 
procaspase-9 level was justified by investigating the cellular level of caspase-9. It was 
found that the amount of capase-9 was elevated upon the Fc treatment. This implies 
that procaspase-9 was activated and cleaved into its active form caspase-9. Caspase-9 
plays a crucial role in the apoptotic pathway, acting as an initiator of the caspase 
cascade downstream (Berger et al., 2006). We also detected the activation of one of 
the major executioners of apoptosis caspase-3. A dose-dependent reduction in the 
level of procapase-3 was observed after treating with Fc. As an inactive zymogen, 
procaspase-3 reduction hinted the possibility of its activation into caspase-3 through 
enzymatic cleavage. In addition, obvious reduction in the level of intact PARP in the 
Fc-treated MDA-MB-231 cells could be observed in a dose-dependent fashion. Such 
reduction in intact PARP level is likely to be caused by its cleavage. PARP is an 
abundant nuclear protein that is involved in the DNA-base-excision-repair system 
(Hong et al., 2004). Cleavage of PARP is an identical event in apoptosis which was 
viewed as a marker of DNA damage and was proposed to be associated with the 
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preventing the access of DNA repair enzymes to the fragmented chromatin (Yu et al., 
2002). 
Elevated level of Bcl-2 expression was found in 80 % of breast cancer patients 
(Krajewski et al., 1999). Members of the Bcl-2 family were associated with the 
regulation of the integrity of the outer mitochondrial membrane (Harris and 
Thompson, 2000) while Bcl-2 is viewed as an survival signal and would prevent the 
release of some caspase activators from mitochondria (Mignotte and Vayssiere, 1998). 
Bcl-2 reduction seen in our results may disturb the balance between pro-apoptotic 
proteins and anti-apoptotic proteins and free the pro-apoptotic proteins from inhibition 
such as Bax and Bak, leading to mitochondrial membrane depolarization and the 
release of cytochrome c (Manion and Hockenbery, 2003). Cytochrome c plays a 
pivotal role in the mitochondrial-dependent apoptotic cell death since its release 
would trigger the formation of apoptosome from Apaf-1, ATP and procaspase-9 
(Baliga and Kumar, 2003) and leads to the allosteric activation of caspase-9. 
Activated caspase-9 then propagates caspase cascade through the proteolytic 
activation of the caspase-3 (Taylor et al., 2008). Since the level of procaspase-3 was 
lowered in our results meanwhile DNA fragmentation could be observed. Therefore, it 
is very likely that the decrease in procaspase-3 level was due to the enzymatic 
activation to activated caspase-3. Once activated, caspase-3 could cleave ICAD and 
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dissociate the ICAD:CAD complex, thereby letting the CAD to cleave the 
chromosomal DNA (Nagata, 2000) and led to the internucleosomal DNA ladder seen 
in gel electrophoresis and sub-Gl peak in cell cycle analysis. 
On the other hand, GO/Gl phase cell cycle arrest could be seen in Fc treated 
MCF-7 cells. Therefore, we have investigated some proteins responsible in regulating 
the cell cycle progression from G1 to S phase through Western analysis. Our results 
indicated dose-dependent reduction in the amount of cyclin Di and cdk 2 in MCF-7 
cells after the treatment with Fc for 48 hours. The replication of eukaryotic cell is 
governed by a tightly controlled programme. One of the most important decision 
making takes place in G1 phase, before the cell commits itself to the replication of its 
DNA in the S phase. There exists a so called G1 restriction point that the cell decides 
whether to proceed to the replication programme or not. Signals from extracellular 
matrix, growth factor or alarm signal generated by DNA damage would decide 
whether the cell would proceed to the next phase of cell cycle (Miele, 2003). Both 
cyclin Di and cdk 2 play a part in the cell cycle restriction check point in the G1 to S 
phase transition. The transition from G1 to S phase requires the sequential 
phosphorylating action of cyclin D / cdk 4 or cyclin D / cdk 6 and then by cyclin E / 
cdk 2 complex on a retinoblastoma protein Rb during late G1 phase (Herwig and 
Strauss, 1997). Originally, the binding of Rb inhibits E2F-dependent transcription, 
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probably by the action of Rb / E2F / HDAC (histone deacetylases) complex which 
inhibits transcription at E2F-dependent promoters by acetylating histories and limiting 
promoter access through chromatin remodeling (Zhang et al., 2000). Phosphorylated 
Rb would dissociate from E2F transcription factor and allow its activation on the 
transcription of genes indispensable for G1 to S phase progression, like DNA 
polymerase, cyclin E and thymidine kinase. As seen in our results, the down regulated 
expression of cdk 2 would hinder the phosphorylation of Rb protein which is needed 
for the transition from G1 to S phase. Since the activation of cdk 4 / cdk 6 requires the 
binding of their partner cyclin Di, reduced cyclin Di would also lead to the decreased 
phosphorylation of Rb protein. As a result, Fc treated MCF-7 cells failed to pass the 
G1 restriction point, progression from G1 to S phase was blocked and therefore 
arrested and accumulated in G1 phase. This justified the results in cell cycle analysis 
in which elevation of cells in G1 phase could be observed in a dose-dependent 
fashion. 
We have studied the effect of Fc on the effect on the proliferation of ER positive 
MCF-7 cells and ER negative MDA-MB-231 cells. The results of MTT assay 
indicated that MCF-7 cells were more responsive to Fc with an IC50 of 42 ^ig/ml while 
the IC50 of MDA-MB-231 cells was 65 |Lig/mL Apart from the responsiveness, the 
mechanism of growth inhibition of Fc on these two cell lines is also different from 
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each other. Fc could induce caspase-dependent apoptosis in MDA-MB-231 cells by 
activating the intrinsic pathway. Reduction in Bcl-2 level, depolarization of 
mitochondrial membrane and activation of caspase-9 and caspase-3 could be seen. 
These result in the apoptotic features like PS extemalization and DNA fragmentation. 
On the other hand, Fc induced G1 phase cell cycle arrest in MCF-7 cells, by reducing 
the expression levels of cyclin D! and cdk 2, therefore blocking the G1 to S phase 
transition. Typical features of apoptosis like PS extemalization and DNA 
fragmentation were absent from the Fc treated MCF-7 cells. It has been reported that 
MCF-7 cells were resistant to apoptosis, because of the lack of caspase-3 due to the 
deletion of casp-3 gene in this cell line (Essmann et al., 2004). Meanwhile, other 
groups have reported that MCF-7 cells could still exhibit apoptosis through the 
sequential activation of caspase-9, caspase-7 and caspase-6 despite the absence of 
caspase-3 (Simstein et a l , 2003). However, the induction of apoptosis in MCF-7 cells 
with such pathway was usually accompanied by the observation of DNA 
fragmentation (Mc Gee et al., 2002;Nigam et al., 2008) or PS extemalization 
(Mooney et al., 2002). Therefore, whether Fc would induce apoptosis in MCF-7 cells 
still remains elusive. However, we are confident to say that the anti-proliferative 
effect of Fc on MCF-7 cells was at least partly contributed by the GO/Gl cell cycle 
arrest. 
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In contrast to the results of MCF-7 cells, no cell cycle arrest was induced by Fc 
in MDA-MB-231 cells. This difference in response in the two cell lines hinted the 
possibility of involvement of ER in the cell cycle arrest action of Fc on MCF-7 cells. 
As an ER-expressing cell line, the proliferation of MCF-7 cells is dependent on the 
estrogen stimulation on the ER. Previously, there are reports about the anti-estrogen 
treatment or removal of estrogen source could lead to the G1 arrestment (Sutherland 
et al., 1983). It has been demonstrated that treatment of ER positive cell line with 
anti-estrogen ICI 182780 would lead to the reduction in level of cdk 2 and cyclin D| 
and cause growth arrest (Bindels et al., 2002). In addition, recent studies suggested 
that cyclin Di itself could activate the ER, and this activation cannot be inhibited by 
the action of anti-estrogen. Instead, a direct binding of cyclin Di to the hormone 
binding domain of the ER would lead to the activation of ER and enhanced the 
transcription of ERE-responsive genes in a cdk-independent fashion (Zwijsen et al., 
1997). Therefore, the reduction of expression level of cyclin Di after treatment with 
Fc may also take a part in suppressive effect of Fc on MCF-7 cells through the 
mediation of ER. 
Our results demonstrated that Acanthopanax exhibited anti-proliferative effect 
on MCF-7, MDA-MB-231 and Hep G2 cells, which has not been reported previously. 
One of the fractions Fc generated from Acanthopanax induced apoptosis in 
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MDA-MB-231 cells and cell cycle arrest in MCF-7 cells. However, we did not have 
clues about the components or active compound responsible for the anti-tumor 
activity in Fc. Therefore, further purification and isolation of active compound in Fc 
would definitely help solving the mist of anti-tumor effect of Acanthopanax on breast 
cancer cells. Studies on the chemical compositions of Acanthopanax suggested that 
lignans, saponins, sterols, flavonoids and polysaccharides could be found in 
Acanthopanax. Compounds including syringin, stearic acid, sesamin, liriodendrin, 
rutin, isofraxidin, chlorogenic acid, p-sitosterol, daucosterol, syringaresinol and 
2,6-dimethoxy-p-benzoquinone have been isolated from Acanthopanax previously (Li 
et al., 2006;Zhou et al., 2007). Sesamin, stearic acid and chlorogenic acid has 
previously been reported to induce apoptosis in other tumor cell lines. However, other 
compounds such as the saponins can still be the potential active constituents in the 
anti-tumor effect of Acanthopanax. 
Moreover, in vivo study of the anti-tumor activity would further confirm the 
findings in this study. Although Fc exhibited anti-tumor activity in the in vitro 
environment, such activities could be abrogated by low absorption or high metabolic 
degradation rate in in vivo settings. In addition, the in vivo experiments would also 
help answering the question of how selective is the effect of Fc and would Fc bring 
severe side effects to cancer patients. Although the effect of Fc on normal human cells 
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like Hs68 cells or PBMC is weaker compared to that on tumor cells, we cannot 
exclude the possibility that Fc may affect the proliferation of other normal human 
tissues that are not tested in this study. In short, in vivo studies would further confirm 
the anti-tumor activities of Acanthopanax extracts. 
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Chapter 5 Conclusion 
The aqueous extract of Acanthopanax exhibited anti-proliferative effect on tumor cell 
lines MCF-7, MDA-MB-231 and Hep G2 and selectivity could be seen on the 
anti-proliferative activity of Acanthopanax when we compared the efficacy in 
inhibiting cancer cells and normal fibroblast Hs68 cells. The breast cancer cell lines 
were more responsive to the suppressive effect of Acanthopanax. After partition and 
column chromatography, it was found that one of the sub-fractions (Fc) in 
ethyl-acetate extract could inhibit the proliferation of MCF-7 and MDA-MB-231 cells 
with IC50 of 42 |Lig/ml and 65 ^ig/ml respectively. Fc inhibited the proliferation of 
human breast cancer cells more effectively than inhibiting the proliferation of human 
normal fibroblast Hs68 cells and PBMC. By flow cytometric analysis and Western 
blotting, it was found that Fc could induce G1 phase cell cycle arrest in MCF-7 cells 
through the reduction of cyclin D, and cdk 2 expression. On the other hand, 
caspase-dependent apoptosis was induced by Fc in MDA-MB-231 cells. Typical 
apoptotic hallmarks such as phosphatidylserine extemalization, mitochondrial 
membrane depolarization and DNA fragmentation could be observed in Fc treated 
MDA-MB-231 cells. The expression of Bcl-2, procaspase-9, procaspase-3 and PARP 
was decreased while expression ofcaspase-9 was increased. Although Acanthopanax 
extract demonstrated anti-tumor effect in in vitro situation, animal study is still needed 
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to further verify the anti-tumor effect of Fc under in vivo condition in the future. 
Besides, further purification of sub-fraction Fc would help identifying the active 
component(s) responsible for the anti-tumor effect in Acanthopanax. 
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